\r\n\tThis edited volume will contain chapters dealing with the different aspects of basic and applied chemical ecology. Scientists working in diverse fields of chemical ecology would contribute high impact articles on chemical ecology and semiochemistry of plants and animals. This book aims to be a rich source of information for the students, teachers and researchers working in this special field of ecological science.
",isbn:null,printIsbn:"979-953-307-X-X",pdfIsbn:null,doi:null,price:0,priceEur:null,priceUsd:null,slug:null,numberOfPages:0,isOpenForSubmission:!1,hash:"b0e57b577bb258d8d3290e46066153b1",bookSignature:"Prof. Sajal Ray",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/6901.jpg",keywords:"Kairomone, Terpenes, Hexadecene, Sex Pheromones, Chemical Defense, Floral Scent Compound, Bisabolene, Linalool, Macrocyclic Lactone, Pinene, Terpinolene, Tritrophic Interaction",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:0,numberOfDimensionsCitations:0,numberOfTotalCitations:0,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"April 16th 2019",dateEndSecondStepPublish:"May 7th 2019",dateEndThirdStepPublish:"July 6th 2019",dateEndFourthStepPublish:"September 24th 2019",dateEndFifthStepPublish:"November 23rd 2019",remainingDaysToSecondStep:"2 years",secondStepPassed:!0,currentStepOfPublishingProcess:5,editedByType:null,kuFlag:!1,biosketch:null,coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"173697",title:"Prof.",name:"Sajal",middleName:null,surname:"Ray",slug:"sajal-ray",fullName:"Sajal Ray",profilePictureURL:"https://mts.intechopen.com/storage/users/173697/images/system/173697.jpeg",biography:"Sajal Ray received his MSc and MPhil degrees from Calcutta University in Zoology and Environmental Science respectively and was awarded Ph.D. from Jadavpur University.\r\nHis thesis reported immunotoxicity of pesticide in an economically important snail of India. As an awardee of Fogarty Visiting Fellowship, Dr. Ray carried out his postdoctoral research in Cardiac pathology at National Institutes of Health, USA. \r\nHis research interest is studying the immunological responses of mollusks, sponge, crab, and earthworm exposed to pollutants. \r\nHis team is engaged in understanding the evolutionary mechanism of immunity in phylogeny. He presented his research at various conferences including the World Congress of Malacology at Washington D.C. Sajal Ray, currently, a Professor of Zoology at Calcutta University has been teaching Zoology for nearly thirty years at postgraduate level.",institutionString:"University of Calcutta",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"5",institution:{name:"University of Calcutta",institutionURL:null,country:{name:"India"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"6",title:"Biochemistry, Genetics and Molecular Biology",slug:"biochemistry-genetics-and-molecular-biology"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"177731",firstName:"Dajana",lastName:"Pemac",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/177731/images/4726_n.jpg",email:"dajana@intechopen.com",biography:"As a Commissioning Editor at IntechOpen, I work closely with our collaborators in the selection of book topics for the yearly publishing plan and in preparing new book catalogues for each season. This requires extensive analysis of developing trends in scientific research in order to offer our readers relevant content. Creating the book catalogue is also based on keeping track of the most read, downloaded and highly cited chapters and books and relaunching similar topics. I am also responsible for consulting with our Scientific Advisors on which book topics to add to our catalogue and sending possible book proposal topics to them for evaluation. Once the catalogue is complete, I contact leading researchers in their respective fields and ask them to become possible Academic Editors for each book project. Once an editor is appointed, I prepare all necessary information required for them to begin their work, as well as guide them through the editorship process. I also assist editors in inviting suitable authors to contribute to a specific book project and each year, I identify and invite exceptional editors to join IntechOpen as Scientific Advisors. I am responsible for developing and maintaining strong relationships with all collaborators to ensure an effective and efficient publishing process and support other departments in developing and maintaining such relationships."}},relatedBooks:[{type:"book",id:"5899",title:"Organismal and Molecular Malacology",subtitle:null,isOpenForSubmission:!1,hash:"a7f042a23fd6991a546812db126ef875",slug:"organismal-and-molecular-malacology",bookSignature:"Sajal Ray",coverURL:"https://cdn.intechopen.com/books/images_new/5899.jpg",editedByType:"Edited by",editors:[{id:"173697",title:"Prof.",name:"Sajal",surname:"Ray",slug:"sajal-ray",fullName:"Sajal Ray"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6344",title:"Biological Resources of Water",subtitle:null,isOpenForSubmission:!1,hash:"ca4f407275697c7cf547debc6b1e85a9",slug:"biological-resources-of-water",bookSignature:"Sajal Ray",coverURL:"https://cdn.intechopen.com/books/images_new/6344.jpg",editedByType:"Edited by",editors:[{id:"173697",title:"Prof.",name:"Sajal",surname:"Ray",slug:"sajal-ray",fullName:"Sajal Ray"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6559",title:"Earthworms",subtitle:"The Ecological Engineers of Soil",isOpenForSubmission:!1,hash:"0780208898e98441ccea18ea373c0708",slug:"earthworms-the-ecological-engineers-of-soil",bookSignature:"Sajal Ray",coverURL:"https://cdn.intechopen.com/books/images_new/6559.jpg",editedByType:"Edited by",editors:[{id:"173697",title:"Prof.",name:"Sajal",surname:"Ray",slug:"sajal-ray",fullName:"Sajal Ray"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8421",title:"Invertebrates",subtitle:"Ecophysiology and Management",isOpenForSubmission:!1,hash:"524faf733c0ebf32b356f89b2148e6de",slug:"invertebrates-ecophysiology-and-management",bookSignature:"Sajal Ray, Genaro Diarte-Plata and Ruth Escamilla-Montes",coverURL:"https://cdn.intechopen.com/books/images_new/8421.jpg",editedByType:"Edited by",editors:[{id:"173697",title:"Prof.",name:"Sajal",surname:"Ray",slug:"sajal-ray",fullName:"Sajal Ray"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6883",title:"Cell Signalling",subtitle:"Thermodynamics and Molecular Control",isOpenForSubmission:!1,hash:"e4e17d85c0643c7f4d274fa9adbcc628",slug:"cell-signalling-thermodynamics-and-molecular-control",bookSignature:"Sajal Ray",coverURL:"https://cdn.intechopen.com/books/images_new/6883.jpg",editedByType:"Edited by",editors:[{id:"173697",title:"Prof.",name:"Sajal",surname:"Ray",slug:"sajal-ray",fullName:"Sajal Ray"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6694",title:"New Trends in Ion Exchange Studies",subtitle:null,isOpenForSubmission:!1,hash:"3de8c8b090fd8faa7c11ec5b387c486a",slug:"new-trends-in-ion-exchange-studies",bookSignature:"Selcan Karakuş",coverURL:"https://cdn.intechopen.com/books/images_new/6694.jpg",editedByType:"Edited by",editors:[{id:"206110",title:"Dr.",name:"Selcan",surname:"Karakuş",slug:"selcan-karakus",fullName:"Selcan Karakuş"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"59334",title:"Skeletal Manifestations of Hyperparathyroidism",doi:"10.5772/intechopen.74034",slug:"skeletal-manifestations-of-hyperparathyroidism",body:'1. Introduction
Over the last hundred years, the effect of parathyroid hormone (PTH) on bone metabolism was extensively discussed. PTH acts on the bone cells through several mediators, and its action involves a variety of cells. It is now understood that parathyroid hormone has both catabolic and anabolic effects on bone metabolism [1]. Mandl in Austria was the first to prove that the enlarged parathyroid was responsible for the skeletal manifestations of hyperparathyroidism after the first successful removal of parathyroid adenoma [2]. The clinical picture of the disease also changed dramatically over the years from a disease of “stones, bones, abdominal groans, thrones and psychiatric overtone” to a disease which can be only detected by elevated calcium and the PTH level on laboratory tests or even the elevated PTH level with no hypercalcemia [2, 3]. This change in clinical presentation was accompanied by the introduction of newer lab tests to assess bone turnover and newer imaging techniques to assess the bone quality [2]. The treatment modalities also evolved, allowing more individualized approach for treating each patient [4].
2. Action of parathyroid hormone on the bone in hyperparathyroidism
The main function of PTH is to maintain calcium levels within the normal range thorough its action on the bone, kidneys, and intestine. It also decreases serum phosphorous through inhibiting renal reabsorption [5, 6]. PTH can produce catabolic or anabolic effect on bone metabolism depending on the level of the hormone, periodicity, and duration of exposure [6, 7]. Primary hyperparathyroidism (PHPT), continuous PTH infusion (cPTH), and intermittent PTH treatment (iPTH) increase bone turnover in trabecular and cortical bone and elevate the markers for bone resorption and formation [2, 8, 9, 10]. PHPT and cPTH enhance cortical bone loss by increasing osteoclastic activity but produce cancellous bone that is relatively preserved or modestly increased [2, 9, 11]. iPTH treatment stimulates trabecular bone formation by osteoblast stimulation and can cause small cortical bone loss [12, 13]. The pattern of bone loss in PHPT is different from the pattern of bone loss in osteoporosis. In osteoporosis, the trabecular bone loss predominates, while in PHPT the cortical bone loss predominates [14].
2.1. Action of parathyroid hormone on bone cells
Normally, bone structural integrity is maintained by the process or remodeling where the bone is removed by osteoclasts and new bone is synthesized by osteoblasts [15]. The osteoclasts and osteoblasts are arranged in a structure called the basic multicellular unit (BMU). A BMU consists of osteoclasts in front with osteoblasts, some blood vessels, and connective tissue behind [16, 17]. Osteoclasts are formed by fusion of mononuclear precursors, while osteoblasts originate from undifferentiated mesenchymal cells [16, 18]. Parathyroid hormone produces its effects by binding to its receptor PPR (also known as PTH-1R). While osteoblasts, osteocytes, and lymphocytes, mesenchymal stromal cells express PPR, osteoclasts respond indirectly to PTH through various mediators and cytokines produced by cells which carry PPR [6, 19, 20, 21, 22, 23]. It is now believed that osteocytes are the primary cellular target of PTH in the bone. Osteocytes are the main cells that express PPR in the musculoskeletal system [14]. Saini et al. designed a study where they generated mice with PPR deletion in osteocytes. These mice showed significant increase in bone mineral density (BMD), reduced osteoblast activity, and decreased skeletal response to anabolic or catabolic PTH regimen [24]. Other studies also supported the fact that osteocytes rather than osteoblasts are the main source of the receptor activator of nuclear factor kappa-B ligand (RANKL) in the process of osteoclastogenesis [25, 26]. Where mice lacking RANKL in osteocytes had less bone loss compared to control mice when they are exposed to dietary calcium deficiency for 30 days causing secondary hyperparathyroidism. There was less RANKL expression and less osteoclast number in the group of mice lacking RANKL [25]. Another study was designed with a co-culture of osteoclast precursors and osteocytes. The study showed that RANKL is provided through dendritic processes of osteocytes to osteoclast precursor and that soluble RANKL had less contribution to osteoclastogenesis [27]. In humans, the RANKL/osteoprotegerin (OPG) ratio is higher in patients with PHPT than controls. This ratio is decreased with parathyroidectomy (PTx) or medical treatment by alendronate [28]. Another study on patients with PHPT showed that RANKL correlated with bone resorption markers in these patients and suggested that it can be used to determine patients of PHPT with greater risk of bone loss [13]. Another study was conducted on patients with PHPT where transiliac bone biopsy was done before PTx and 12 months after surgery and mRNA for RANKL and OPG were measured. The study showed that the mRNA ratio of RANKL/OPG decreased significantly after surgery [13].
PTH increases RANKL/OPG ratio with continuous exposure to high dose which produces catabolic effect as in hyperparathyroidism. This results in increased bone turnover, osteopenia, and bone loss in hyperparathyroidism. In addition, several extraskeletal manifestations of hyperparathyroidism are due to increased bone catabolism and hypercalcemia as nephrolithiasis, renal failure, peptic ulcer, and mental changes [2]. On the other hand, intermittent low-dose exposure to PTH has an anabolic effect through the SOST/sclerostin pathway [6].
The OPG-RANK-RANKL pathway is the mechanism by which hyperparathyroidism induces bone catabolism. PTH regulates the production of RANKL and its soluble decoy receptor OPG by osteoblasts and osteocytes [29, 30, 31]. RANKL binds to the receptor activator of nuclear factor kappa-B (RANK) on the osteoclast precursor stimulating their differentiation to osteoclasts and on the surface of the osteoclasts increasing their bone-resorbing activity. OPG inhibits the action of RANKL by binding to RANKL, thus preventing its access to the receptor RANK. In this way, the process of bone resorption is controlled by the balance between the concentration of RANKL and OPG [32, 33, 34, 35, 36]. In rats, continuous infusion of human PTH increased RANKL and RANKL mRNA expression and decreased OPG and OPG mRNA [37]. In vitro studies also showed that PTH activates of cAMP/PKA–CREB pathway increase the Tnfsf11 gene encoding RANKL, whereas a PTH inhibits the mRNA encoding for OPG expression through a PKA-CREB-AP-1 pathway [38, 39, 40].
2.2. Effect of parathyroid hormone on cells of the bone marrow and cells of the immune system
Cells of bone marrow also play a role in the effect of PTH on bone metabolism. Lymphocytes are believed to play a role on bone metabolism. T lymphocytes express PPR [23]. T cells express RANKL and CD40L on their surface that binds with RANK and CD40 in osteoclast precursors and osteoclasts to stimulate them [13, 41, 42]. Th17 cells form a subset of T lymphocytes that contribute to bone resorption. TH17 cells secrete IL-17, RANKL, TNF-α, IL-1, and IL-6, along with low levels of IFN-γ which contribute to osteoclastogenesis [43, 44, 45, 46]. IL-17 stimulates the secretion of RANKL by osteoblasts and osteocytes and upregulates RANK [46, 47]. This is consistent with a human study that showed statistically significant elevation of IL-17 in postmenopausal women who had osteoporosis when compared with postmenopausal women who had osteopenia [47]. It is also noted that cPTH stimulates the production of TGF-β, IL-6, and TNF-α by bone cells and stromal cells [7, 48, 49]. TGF-β and IL-6 direct the differentiation of naive CD4+ cells into TH17 cells [50, 51, 52]. TNF-α plays also an important role as a mediator of PTH catabolic action. PTH stimulates T cells to produce TNF-α. In mice lacking T-cell TNF-α, PTH failed to produce bone resorption but did not affect bone formation. Thus, in these mice there was no cortical bone loss, and there was increased trabecular bone formation [19]. TNF-α stimulates osteoclast formation and activity by multiple mechanisms. TNF-α increases the production of RANKL by osteoblasts and osteocytes. It also increases the expression of CD40 by stromal cells and osteoblasts increasing their responsiveness to CD40L expressed by T cells. Activation of CD40 on stromal cells and osteoblasts decreases the OPG secretion, thus increasing the RANKL/OPG ratio [7].
Bone marrow macrophages also play a role in the action of PTH on the bone. Macrophages express PPR. Depletion of the precursors of macrophages decreases the anabolic effect of iPTH [19]. The monocyte chemoattractant protein-1 (MCP-1) which is a chemotactic factor for monocyte and macrophages is a mediator for PHT-induced bone resorption [6]. MCP-1 was proven to attract pre-osteoclast in in vitro studies, thus increasing bone resorption [53]. It was found that the expression for MCP-1 increased by cPTH and iPTH in rat osteoblastic cells. With cPTH the MCP-1 expression was sustained, while with the anabolic protocol, the expression of MCP-1 was transient yet more pronounced. This suggests that the transient increase of bone resorption may be necessary before the anabolic effect of PTH on the bone [53, 54]. In human studies, MCP-1 levels correlate with PTH levels in patients with PHPT. After PTx, the levels of MCP-1 decreased significantly starting from 15 minutes following parathyroid adenoma removal [55].
3. Skeletal abnormalities in symptomatic hyperparathyroidism
3.1. Incidence
Hyperparathyroidism was first described in 1891 by von Recklinghausen. Despite of the fact that primary hyperparathyroidism was classically described as disease of “stones, bones, abdominal groans, thrones, and psychiatric overtone,” the presentation of the disease changed dramatically over the past decades. Nowadays, the classical presentation with osteitis fibrosa cystica and pathological fractures is rarely seen in developed countries. Currently, larger numbers of patients are being identified with neuropsychiatric or cardiac manifestation and laboratory studies in the USA and Europe [2, 56]. In developing countries, the symptomatic form of PHPT was prevalent for a long time, but some countries as Brazil and China are having a shift toward the asymptomatic disease. However, other countries as India, Iran, Saudi Arabia, and Thailand still have high prevalence of the symptomatic form of the disease with pronounced skeletal manifestations [56, 57, 58].
3.2. Clinical manifestations
The signs and symptoms of severe bone disease include bone pain and pathologic fractures. Skeletal muscles are also affected by hyperparathyroidism where the patients have proximal muscle weakness and hyperreflexia [2, 59].
One of the features of skeletal involvement in hyperparathyroidism is hungry bone syndrome. It is characterized by hypocalcemia and hypophosphatemia following PTx. It is thought to be due to withdrawal of osteoclast stimulation by high levels of PTH. This condition is treated by high doses of calcium and vitamin D [60, 61].
3.3. Investigations
3.3.1. Imaging
3.3.1.1. Radiography
Plain X-rays can show the classical findings of osteitis fibrosa cystica. This is characterized by marked thinning of the cortex (demineralization). Salt and pepper appearance for skull X-rays is also seen. Bone resorption of distal third of the clavicle is also seen. Hand X-rays show subperiosteal bone erosions in the distal phalanges and the lateral aspects of middle phalanges. Lytic lesions can also be seen in the pelvis and long bones with pathological fractures. Lytic lesions are referred to as brown tumors; these are a mixture of hemosiderin (hence, the brown color on pathological examination), woven bone, fibrous tissue, and osteoclasts. However, the lesions are nonneoplastic [2].
3.3.1.2. Bone mineral density
Bone mineral density can be measured by dual energy X-ray absorptiometry (DEXA) scan in all patients where measurements should be taken for lumbar spine, hip regions (total hip and femoral neck), and distal 1/3 of the radius. It is important to measure the bone mineral density in distal radius as it is a cortical site, and hyperparathyroidism is known to have catabolic effect on cortical bone [2, 56].
3.3.1.3. High-resolution peripheral quantitative computed tomography (HR-pQCT)
This is a noninvasive technique that allows assessment of the cortical and trabecular bone quality in PHPT [56]. HR-pQCT measures volumetric bone density, bone geometry, skeletal microarchitecture, and bone strength in the cortical and trabecular compartments. HR-pQCT showed that microarchitectural deterioration in both cortical and cancellous sites has decreased volumetric densities, more widely spaced, and heterogeneously distributed trabeculae and thinner cortices [62, 63, 64].
3.3.1.4. Trabecular bone score (TBS)
TBS is obtained from DEXA scan by applying special software. It is a textural analysis that provides an indirect index of trabecular microarchitecture. It can differentiate between DEXA scans showing similar bone densities. A high TBS is associated with a dense trabecular network and greater bone strength, and a low TBS indicates poor microarchitecture and poor strength [65, 66, 67].
3.3.2. Histomorphometry
Histomorphometry of transiliac biopsy will show reduced width of the cortex with increased porosity, while the trabecular bone is preserved [14].
3.3.3. Laboratory tests
In severe PHPT, serum calcium and parathormone are elevated. There are special markers for bone elevation as osteocalcin, type I procollagen peptide, and alkaline phosphatase. Alkaline phosphatase is much above the normal in all cases of hyperparathyroidism with increased bone turnover. Markers of bone resorption are also typically elevated PHPT. These include deoxypyridinoline, N-telopeptide, and C-telopeptide. These markers are products of breakdown of type 1 collagen [2]. Renal functions and urinary calcium should be evaluated. 25OH vitamin D levels should be as lower as the levels of 25OH vitamin D correlate with higher bone turnover and lower BMD, and both improve with repletion of 25OH vitamin D [68, 69].
4. Skeletal abnormalities in asymptomatic primary hyperparathyroidism
4.1. Manifestations
In 1970s, the wide availability of measurement of serum calcium changed the clinical presentation of hyperparathyroidism giving rise to the entity of asymptomatic primary hyperparathyroidism [14]. These are patients with hypercalcemia and elevated PTH but who are discovered accidentally while doing laboratory studies [58]. These patients have no X-ray finding of symptomatic hyperparathyroidism previously described [58]. These patients show decreased bone mass in cortical sites when measured by DEXA scan. Thus, DEXA scan shows reduction of bone mineral density at distal 1/3 of forearm (which is composed primarily of cortical bone), while bone density of lumbar spine (which is formed mainly of trabecular bone) is preserved. However, bone scan may remain stable for years in patients with asymptomatic hyperparathyroidism. Rubin et al. noted that the BMD of the lumbar spine remained stable for 15 years while it started to fall in cortical sites before 10 years [70, 71]. Micro-CT and histomorphometric studies show reduction of cortical bone with preservation of cancellous bone in PHPT [70, 71]. However, clinical studies showed that patients with hyperparathyroidism have higher risk of fractures both at cortical and cancellous sites [72, 73]. HR-pQCT helped to resolve this controversy. HR-pQCT showed that microarchitectural deterioration in both cortical and cancellous sites has decreased volumetric densities, more widely spaced, and heterogeneously distributed trabeculae and thinner cortices [62, 63, 64]. These studies also highlighted that weight bearing is a factor that can prevent the microarchitectural deterioration where they showed that the radius is more negatively affected than the tibias [63, 64]. Stein et al. performed individual trabecula segmentation that gave an insight into the trabecular microstructure. They found that the number of plate-like trabeculae is reduced relative to the rod-like trabeculae (decrease P-R ratio); there is reduced connectivity and less axially aligned trabecular network [64]. Another imaging modality which can show skeletal affection in asymptomatic cases is the trabecular bone score (TBS). Romagnoli et al. showed that TBS was significantly lower in patients with PHPT compared to controls. Among patients with PHPT, TBS was significantly lower in patients with vertebral fractures when compared to patients without vertebral fractures [74]. Eller-Vainicher et al. showed that TBS was associated with vertebral fractures regardless of age, gender, BMD, and BMI [75].
4.2. Natural history of bone disease in asymptomatic hyperparathyroidism
Age and female genders are associated with higher fracture risk in PHPT [73]. Currently, it is still unclear whether fracture risk assessment tools as FRAX can help to predict risk of fractures in patients with PHPT or not [14]. Concerning changes in BMD over time, Rao et al. monitored 80 patients with asymptomatic PHPT for a mean of 46 month. They did not observe deterioration of biochemical markers nor BMD measurements [74]. Silverberg et al. followed up 121 patients with PHPT of whom 101 were asymptomatic for up to 10 years. Twenty-five percent of patients showed disease progression. They also noted that patients younger than 50 years old had more likelihood of disease progression [71]. Rao et al. conducted randomized controlled trial on patients with PHPT and concluded that BMD at the hip and spine improves after PTx [76]. Rubin et al. studied 116 patients with PHPT of whom 99 were asymptomatic, PTX improved the biochemical markers and BMD, and without surgery PHPT progressed in one third of the cases [76]. Eller-Vainicher et al. studied 92 patients with PHPT and 98 controls for 24 months. DEXA scan and TBS in patients treated surgically and conservatively. In the surgical group, BMD and TBS increased significantly although it remained lower than controls. In the conservative group, BMD showed a decrease which was not statistically significant, and TBS showed a decrease which was not statistically significant; except in three patients who had vertebral fractures, the TBS showed a statistically significant decrease [75]. Hansen et al. measured BMD and HR-pQCT in women with PHPT before and 1 year after PTx. BMD improved after PTx, and HR-pQCT showed improvement of the cortical and trabecular parameters of the radius and tibia [77].
5. Skeletal abnormalities in normocalcemic primary hyperparathyroidism
5.1. Manifestations
This is a cohort of patients which includes patients with normal total and ionized calcium but elevated PTH in the absence of causes of secondary hyperparathyroidism. This may be due to target organ resistance of the bone and kidney, or these patients are in early stages of the disease [78, 79]. Lowe et al. described a cohort of patients in whom 57% had osteoporosis, 11% had fragility fractures, and 14% had renal stones [80]. Amaral et al. compared normocalcemic to hypercalcemic PHPT patients. They found that 15% of normocalcemic patients had previous fractures compared to 10.8% of normocalcemic patients and the incidence of renal stones was 18.2 in normocalcemic vs. 18.9% of hypercalcemic patients [80]. Charopoulos et al. used peripheral quantitative CT to compare the effect of normocalcemic PHPT to the effect of hypercalcemic PHPT on volumetric BMD and bone geometry. They noted the catabolic effect on both groups although it is more severe in the hypercalcemic group. In the normocalcemic group, cortical properties were adversely affected, while the trabecular properties were preserved [80].
5.2. Natural history of bone disease in asymptomatic hyperparathyroidism
The natural history of bone loss in normocalcemic hyperparathyroidism is not fully defined. Lowe et al. showed decrease in BMD by at least 5% in 43% of the patients [80]. Koumakis et al. measured BMD before and 12 months after PTx for patients with normocalcemic and hypercalcemic PHPT. Both groups showed statistically significant improvement of BMD at the postoperative measurement [14].
6. Treatment
6.1. Effect of surgery on the skeletal manifestations of hyperparathyroidism
Skeletal affection is among the indications of surgery in hyperparathyroidism. Even in asymptomatic cases, surgery is suggested for perimenopausal or postmenopausal women and men 50 years or older who have a T-score of −2.5 or less for any skeletal site. In premenopausal women and men under 50 years old, T-score of less than −2.5 is the cutoff for surgery. The presence of fragility fractures is also among the surgical indication [2, 4, 81].
Surgery improves the bone turnover marker and PTH level. Within the first year following surgery, the BMD improves [70, 71, 82, 83]. This is due to uncoupling of bone resorption where the osteoclast stimulation by PTH stops, while bone formation continues [84]. Rubin et al. showed that the gain in BMD was sustainable up to 15 years following surgery at cortical and cancellous sites despite of expected age-related losses in BMD. The increases in BMD were recorded in the study at years 1, 5, and 10 and showed that the lumbar spine increased to 9, 6, and 12%; the femoral neck 1, 7, and 10%; and the distal radius 4, 8, and 7% [70]. Christiansen et al. studied the BMD and bone turnover markers for the first 6 months after surgery. They reported that the bone turnover markers were normalized and increased bone density in regions rich in cancellous bone but not cortical bone [82]. Similarly, Silverberg et al. noted improvement of BMD in lumbar spine and femoral neck but not the radius [71]. This may be explained by the fact that remodeling in cortical sites is slower than in trabecular bone. Thus, it takes a longer time for changes to be more pronounced [70]. Surgery also decreases the risk of fractures in hyperparathyroidism [72, 85, 86]. Vestergaard et al. demonstrated that the risk of fractures started to increase 10 years prior to surgery and reached its maximum 5–6 years following surgery. This risk falls back to normal after surgery [72]. Rudser et al. compared patients on dialysis who receive PTx to patients on dialysis without PTx. Fracture risks were lower among hemodialysis patients who underwent PTx compared to the dialysis patients who did not undergo PTx [84].
6.2. Effect of pharmacological treatment on skeletal manifestations of hyperparathyroidism
6.2.1. Bisphosphonates
Bisphosphonates (BP) are used in treatment of hyperparathyroidism as they act by inhibiting osteoclastic activity which is the cause of hypercalcemia and bone loss [2]. Several studies assessed the use of alendronate in hyperparathyroidism. Studies reported a reduction in the level of bone turnover markers and an increase in BMD. The increase in BMD was more for the trabecular than the cortical sites [87, 88, 89, 90, 91, 92]. Although alendronate can lower the serum calcium initially, serum calcium tends to rise over 6 months, and the level of PTH may increase more than the pretreatment level [2, 90, 91, 92, 93]. Pamidronate in several studies showed lowering of the serum calcium. However, due to limited time frame, no changes in BMD nor complications were reported [94, 95, 96, 97, 98, 99, 100]. Clodronate use was associated with lowering of the serum calcium [101, 102, 103]. Several studies using clodronate reported lowering of urinary hydroxyproline and hence decreased bone turnover [101, 102, 103]. The use of risedronate in treatment of hyperparathyroidism was assessed in few studies [104, 105]. Tournis et al. reported that surgery is superior to risedronate as it improved the BMD and trabecular mineralization. Risedronate treatment in their study did not result in significant change in volumetric BMD or peripheral quantitative computed tomography [104]. A small number of studies reported the use of several BPs. Lee et al. reported the can prevent hungry bone syndrome among a very small number of patients [104]. Two other studies reported increase in BMD in the lumbar spine and hip [85, 106].
In conclusion, alendronate is the most studied BP in hyperparathyroidism. It decreases bone turnover and increased BMD. The effect of alendronate on serum calcium appears to be short lived.
6.2.2. Cinacalcet
This is a calcimimetic agent which increases the sensitivity of calcium-sensing receptors of the parathyroid gland to calcium, thus decreasing PTH secretion [107]. The effect of cinacalcet on bone turnover markers and BMD appears to be controversial. Several studies measured bone turnover markers with either decrease in the markers [108], no change [109, 110], or increase in the level of the markers [111, 112]. Similarly, the reported effects on BMD were an increase in BMD [113], a decrease [114], and no change [108, 111, 112]. Faggiano et al. compared cinacalcet monotherapy with cinacalcet with alendronate. The patients who received the combined therapy had better improvement of BMD in lumbar spine and hip compared to the monotherapy group. There was no significant difference between biochemical changes in both groups [108]. Moe et al. studied the effect of cinacalcet in reducing the fracture risk in patients receiving hemodialysis. There was no significant effect of cinacalcet on fracture reduction in the intention-to-treat analysis. However, a lag-sensoring analysis which took into consideration the crossover effect showed significant reduction of fracture risk in patients who received cinacalcet [84].
6.2.3. Vitamin D and calcium
Dietary calcium deficiency can induce elevation of PTH levels. Low vitamin D levels are associated with increased bone turnover, deteriorated hip geometry, and lower BMD [68, 84, 115]. Patients with low calcium intake and PHPT who received calcium supplementation had lower levels of PTH and improved BMD of femoral neck [116]. For patients with vitamin D deficiency, vitamin D repletion may decrease PTH levels and improved bone mineral density [116, 117, 118]. However, vitamin D supplementation may slightly increase serum calcium levels and urinary calcium excretion; thus, monitoring of calcium levels is valuable [81, 119, 120].
6.2.4. Other treatments of hyperparathyroidism which affect bone metabolism
Estrogen was found to improve BMD in women with hyperparathyroidism. The BMD of the lumbar spine and femoral neck increases, and bone turnover markers decrease with estrogen administration which has no or minimal effect on serum calcium [121, 122]. Raloxifene was also associated with improved BMD in PHPT [123, 124]. However, there is no data on the effect of estrogen or raloxifene on reducing the risk of fracture [120].
Denosumab is a monoclonal antibody against RANKL that inhibits the binding of RANKL to RANK [125]. A study was conducted on patients with secondary hyperparathyroidism on dialysis in whom denosumab was administered. The BMD improved in the femoral neck and lumbar spine. However, a transient increase in PTH levels occurred in the patients.
7. Conclusion
Despite of the fact that many patients with hyperparathyroidism do not show symptoms of skeletal affection, clinicians always need to keep an eye on the catabolic effect of hyperparathyroidism on the skeletal system. Better understanding of the mechanism of action of PTH of bone showed that many cells and mediators can influence the RANK/RANKL/OPG system, namely, T lymphocytes. Newer imaging modalities as TBS and HR-pQCT can be useful for detecting subtle bony changes. While parathyroidectomy is proven to reverse the skeletal effects of hyperparathyroidism, many patients may not be indicated for surgery, yet they should receive medical treatment that will protect them from the catabolic effect on the bone. Alendronate was extensively studied and showed to decrease bone turnover and increase BMD. Vitamin D supplementation for patients with vitamin D deficiency has a protective effect on the bone. Denosumab also has a protective effect, but clinical data about its use for patients with hyperparathyroidism is still limited.
Acknowledgments
I would like to thank Assistant Professor Stephen Mendelson (Assistant Professor in Department of Orthopedic Surgery in University of Pittsburgh, USA) and Professor Sherif Khaled (Professor of Orthopedic Surgery in Faculty of Medicine, Cairo University, Egypt) for their endless support to accomplish this work.
Conflict of interest
The author has no conflict of interests to declare.
\n',keywords:"osteitis fibrosa cystica (OFC), bisphosphonates, brown tumor, RANKL, parathyroid hormone, bone metabolism",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/59334.pdf",chapterXML:"https://mts.intechopen.com/source/xml/59334.xml",downloadPdfUrl:"/chapter/pdf-download/59334",previewPdfUrl:"/chapter/pdf-preview/59334",totalDownloads:556,totalViews:362,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,dateSubmitted:"September 13th 2017",dateReviewed:"January 15th 2018",datePrePublished:"February 14th 2018",datePublished:"June 6th 2018",dateFinished:null,readingETA:"0",abstract:"The presentation of hyperparathyroidism changed over the last decades which gave rise to more variable presentations than before. Hyperparathyroidism has a catabolic effect on the skeleton whether the disease is symptomatic or asymptomatic or normocalcemic. It is now understood that the effect of parathyroid hormone (PTH) on the bone is mediated by complex interaction between different bone cells and cells of the immune system especially T lymphocytes. Protecting the skeletal system against bone loss and pathological fractures is among the important treatment goals of hyperparathyroidism. To achieve this goal, more complex laboratory tests to monitor the bone turnover and imaging techniques and modalities as high-resolution peripheral quantitative computed tomography (HR-pQCT) and trabecular bone score (TBS) are employed. These imaging techniques showed the affection of microarchitecture of the cortical and the trabecular bone. For the time being, surgery and alendronate treatment are believed to reverse the catabolic effect of hyperparathyroidism on the bone. Vitamin D supplementation in case of vitamin D deficiency may also has a protective effect on the skeleton.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/59334",risUrl:"/chapter/ris/59334",book:{slug:"anatomy-posture-prevalence-pain-treatment-and-interventions-of-musculoskeletal-disorders"},signatures:"Ahmed Khedr",authors:[{id:"221546",title:"Dr.",name:"Ahmed",middleName:null,surname:"Khedr",fullName:"Ahmed Khedr",slug:"ahmed-khedr",email:"ahmedkhedr@kasralainy.edu.eg",position:null,institution:null}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Action of parathyroid hormone on the bone in hyperparathyroidism",level:"1"},{id:"sec_2_2",title:"2.1. Action of parathyroid hormone on bone cells",level:"2"},{id:"sec_3_2",title:"2.2. Effect of parathyroid hormone on cells of the bone marrow and cells of the immune system",level:"2"},{id:"sec_5",title:"3. Skeletal abnormalities in symptomatic hyperparathyroidism",level:"1"},{id:"sec_5_2",title:"3.1. Incidence",level:"2"},{id:"sec_6_2",title:"3.2. Clinical manifestations",level:"2"},{id:"sec_7_2",title:"3.3. Investigations",level:"2"},{id:"sec_7_3",title:"3.3.1. Imaging",level:"3"},{id:"sec_7_4",title:"3.3.1.1. Radiography",level:"4"},{id:"sec_8_4",title:"3.3.1.2. Bone mineral density",level:"4"},{id:"sec_9_4",title:"3.3.1.3. High-resolution peripheral quantitative computed tomography (HR-pQCT)",level:"4"},{id:"sec_10_4",title:"3.3.1.4. Trabecular bone score (TBS)",level:"4"},{id:"sec_12_3",title:"3.3.2. Histomorphometry",level:"3"},{id:"sec_13_3",title:"3.3.3. Laboratory tests",level:"3"},{id:"sec_16",title:"4. Skeletal abnormalities in asymptomatic primary hyperparathyroidism",level:"1"},{id:"sec_16_2",title:"4.1. Manifestations",level:"2"},{id:"sec_17_2",title:"4.2. Natural history of bone disease in asymptomatic hyperparathyroidism",level:"2"},{id:"sec_19",title:"5. Skeletal abnormalities in normocalcemic primary hyperparathyroidism",level:"1"},{id:"sec_19_2",title:"5.1. Manifestations",level:"2"},{id:"sec_20_2",title:"5.2. Natural history of bone disease in asymptomatic hyperparathyroidism",level:"2"},{id:"sec_22",title:"6. Treatment",level:"1"},{id:"sec_22_2",title:"6.1. Effect of surgery on the skeletal manifestations of hyperparathyroidism",level:"2"},{id:"sec_23_2",title:"6.2. Effect of pharmacological treatment on skeletal manifestations of hyperparathyroidism",level:"2"},{id:"sec_23_3",title:"6.2.1. Bisphosphonates",level:"3"},{id:"sec_24_3",title:"6.2.2. Cinacalcet",level:"3"},{id:"sec_25_3",title:"6.2.3. Vitamin D and calcium",level:"3"},{id:"sec_26_3",title:"6.2.4. Other treatments of hyperparathyroidism which affect bone metabolism",level:"3"},{id:"sec_29",title:"7. Conclusion",level:"1"},{id:"sec_30",title:"Acknowledgments",level:"1"},{id:"sec_33",title:"Conflict of interest",level:"1"}],chapterReferences:[{id:"B1",body:'[Malluche HH, Koszewski N, Monier-Faugere MC, Williams JP, Mawad H. Influence of the parathyroid glands on bone metabolism. European Journal of Clinical Investigation. 2006;36(Suppl 2):23-33]'},{id:"B2",body:'[Elizabeth A, Streeten MAL. Hyperparathyroidism, primary. In: Martini L, editor. Encyclopedia of Endocrine Disease. Amsterdam: Elsevier; 2004. p. 558-566]'},{id:"B3",body:'[Habib Z, Camacho P. Primary hyperparathyroidism: An update. Current Opinion in Endocrinology, Diabetes, and Obesity. 2010;17(6):554-560]'},{id:"B4",body:'[Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism. Lancet (London, England). 2017]'},{id:"B5",body:'[Civitelli R, Ziambaras K. Calcium and phosphate homeostasis: Concerted interplay of new regulators. Journal of Endocrinological Investigation. 2011;34(7 Suppl):3-7]'},{id:"B6",body:'[Silva BC, Bilezikian JP. Parathyroid hormone: Anabolic and catabolic actions on the skeleton. Current Opinion in Pharmacology. 2015;22:41-50]'},{id:"B7",body:'[Pacifici R. T cells, osteoblasts, and osteocytes: Interacting lineages key for the bone anabolic and catabolic activities of parathyroid hormone. Annals of the New York Academy of Sciences. 2016;1364(1):11-24]'},{id:"B8",body:'[Iida-Klein A, Lu SS, Kapadia R, Burkhart M, Moreno A, Dempster DW, et al. Short-term continuous infusion of human parathyroid hormone 1-34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL/J6 mice. The Journal of Endocrinology. 2005;186(3):549-557]'},{id:"B9",body:'[Zhou H, Shen V, Dempster DW, Lindsay R. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat. Journal of Bone and Mineral Research. 2001;16(7):1300-1307]'},{id:"B10",body:'[Dempster DW, Parisien M, Silverberg SJ, Liang XG, Schnitzer M, Shen V, et al. On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism. 1999;84(5):1562-1566]'},{id:"B11",body:'[Hock JM, Gera I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. Journal of Bone and Mineral Research. 1992;7(1):65-72]'},{id:"B12",body:'[Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster J-Y, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. The New England Journal of Medicine. 2001;344(19):1434-1441]'},{id:"B13",body:'[Nakchbandi IA, Lang R, Kinder B, Insogna KL. The role of the receptor activator of nuclear factor-κB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism. 2008;93(3):967-973]'},{id:"B14",body:'[Koumakis E, Souberbielle J-C, Sarfati E, Meunier M, Maury E, Gallimard E, et al. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism. 2013;98(8):3213-3220]'},{id:"B15",body:'[Parfitt AM. Skeletal heterogeneity and the purposes of bone remodeling: Implications for the understanding of osteoporosis. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. 2nd ed. Florida: Academic Press; 2001. p. 433-477]'},{id:"B16",body:'[Manolagas SC. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrine Reviews. 2000;21(2):115-137]'},{id:"B17",body:'[Parfitt AM. Osteonal and hemi-osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone. Journal of Cellular Biochemistry. 1994;55(3):273-286]'},{id:"B18",body:'[Owen M. The origin of bone cells in the postnatal organism. Arthritis and Rheumatism. 1980;23(10):1073-1080]'},{id:"B19",body:'[Cho SW, Soki FN, Koh AJ, Eber MR, Entezami P, Park SI, et al. Osteal macrophages support physiologic skeletal remodeling and anabolic actions of parathyroid hormone in bone. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(4):1545-1550]'},{id:"B20",body:'[Lanske B, Amling M, Neff L, Guiducci J, Baron R, Kronenberg HM. Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. The Journal of Clinical Investigation. 1999;104(4):399-407]'},{id:"B21",body:'[Calvi LM, Sims NA, Hunzelman JL, Knight MC, Giovannetti A, Saxton JM, et al. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. The Journal of Clinical Investigation. 2001;107(3):277-286]'},{id:"B22",body:'[Powell WF, Barry KJ, Tulum I, Kobayashi T, Harris SE, Bringhurst FR, et al. Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses. The Journal of Endocrinology. 2011;209(1):21-32]'},{id:"B23",body:'[Terauchi M, Li J-Y, Bedi B, Baek K-H, Tawfeek H, Galley S, et al. T lymphocytes amplify the anabolic activity of parathyroid hormone through Wnt10b signaling. Cell Metabolism. 2009;10(3):229-240]'},{id:"B24",body:'[Saini V, Marengi DA, Barry KJ, Fulzele KS, Heiden E, Liu X, et al. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH. The Journal of Biological Chemistry. 2013;288(28):20122-20134]'},{id:"B25",body:'[Xiong J, Piemontese M, Thostenson JD, Weinstein RS, Manolagas SC, O’Brien CA. Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency. Bone. 2014;66:146-154]'},{id:"B26",body:'[Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng JQ, et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nature Medicine. 2011;17(10):1231-1234]'},{id:"B27",body:'[Honma M, Ikebuchi Y, Kariya Y, Hayashi M, Hayashi N, Aoki S, et al. RANKL subcellular trafficking and regulatory mechanisms in osteocytes. Journal of Bone and Mineral Research. 2013;28(9):1936-1949]'},{id:"B28",body:'[Szymczak J, Bohdanowicz-Pawlak A. Osteoprotegerin, RANKL, and bone turnover in primary hyperparathyroidism: The effect of parathyroidectomy and treatment with alendronate. Hormone and Metabolic Research. 2013;45(10):759-764]'},{id:"B29",body:'[O’Brien CA, Nakashima T, Takayanagi H. Osteocyte control of osteoclastogenesis. Bone. 2013;54(2):258-263]'},{id:"B30",body:'[Kanzawa M, Sugimoto T, Kanatani M, Chihara K. Involvement of osteoprotegerin/osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells. European Journal of Endocrinology. 2000;142(6):661-664]'},{id:"B31",body:'[Lee S-K, Lorenzo JA. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: Correlation with osteoclast-like cell formation 1. Endocrinology. 1999;140(8):3552-3561]'},{id:"B32",body:'[Khosla S. Minireview: The OPG/RANKL/RANK system. Endocrinology. 2001;142(12):5050-5055]'},{id:"B33",body:'[Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proceedings of the National Academy of Sciences of the United States of America. 1998;95(7):3597-3602]'},{id:"B34",body:'[Fuller K, Wong B, Fox S, Choi Y, Chambers TJ. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. The Journal of Experimental Medicine. 1998;188(5):997-1001]'},{id:"B35",body:'[Simonet WS, Lacey D, Dunstan CR, Kelley MCMS, Chang M, Lüthy R, et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell. 1997;89(2):309-319]'},{id:"B36",body:'[Kearns AE, Khosla S, Kostenuik PJ. Receptor activator of nuclear factor κB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocrine Reviews. 2008;29(2):155-192]'},{id:"B37",body:'[Ma YL, Cain RL, Halladay DL, Yang X, Zeng Q, Miles RR, et al. Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology. 2001;142(9):4047-4054]'},{id:"B38",body:'[Fu Q, Jilka RL, Manolagas SC, O’Brien CA. Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein. The Journal of Biological Chemistry. 2002;277(50):48868-48875]'},{id:"B39",body:'[Lee S-K, Lorenzo JA. Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures. Bone. 2002;31(1):252-259]'},{id:"B40",body:'[Kondo H, Guo J, Bringhurst FR. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. Journal of Bone and Mineral Research. 2002;17(9):1667-1679]'},{id:"B41",body:'[Pacifici R. Osteoimmunology and its implications for transplantation. American Journal of Transplantation. 2013;13(9):2245-2254]'},{id:"B42",body:'[Di Rosa F. T-lymphocyte interaction with stromal, bone and hematopoietic cells in the bone marrow. Immunology and Cell Biology. 2009;87(1):20-29]'},{id:"B43",body:'[Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. Journal of Immunology. 1998;160(7):3513-3521]'},{id:"B44",body:'[Waisman A. T helper cell populations: As flexible as the skin? European Journal of Immunology. 2011;41(9):2539-2543]'},{id:"B45",body:'[Komatsu N, Takayanagi H. Autoimmune arthritis: The interface between the immune system and joints. Advances in Immunology. 2012:45-71]'},{id:"B46",body:'[Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. The Journal of Experimental Medicine. 2006;203(12):2673-2682]'},{id:"B47",body:'[Adamopoulos IE, Chao C-C, Geissler R, Laface D, Blumenschein W, Iwakura Y, et al. Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors. Arthritis Research & Therapy. 2010;12(1):R29]'},{id:"B48",body:'[Koh AJ, Novince CM, Li X, Wang T, Taichman RS, McCauley LK. An irradiation-altered bone marrow microenvironment impacts anabolic actions of PTH. Endocrinology. 2011;152(12):4525-4536]'},{id:"B49",body:'[Löwik CW, van der Pluijm G, Bloys H, Hoekman K, Bijvoet OL, Aarden LA, et al. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis. Biochemical and Biophysical Research Communications. 1989;162(3):1546-1552]'},{id:"B50",body:'[Basu R, Hatton RD, Weaver CT. The Th17 family: Flexibility follows function. Immunological Reviews. 2013;252(1):89-103]'},{id:"B51",body:'[Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235-238]'},{id:"B52",body:'[Martinez GJ, Nurieva RI, Yang XO, Dong C. Regulation and function of proinflammatory TH17 cells. Annals of the New York Academy of Sciences. 2008;1143(1):188-211]'},{id:"B53",body:'[Li X, Qin L, Bergenstock M, Bevelock LM, Novack DV, Partridge NC. Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts. The Journal of Biological Chemistry. 2007;282(45):33098-33106]'},{id:"B54",body:'[Tamasi JA, Vasilov A, Shimizu E, Benton N, Johnson J, Bitel CL, et al. Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone. Journal of Bone and Mineral Research. 2013;28(9):1975-1986]'},{id:"B55",body:'[Patel H, Trooskin S, Shapses S, Sun W, Wang X. Serum monocyte chemokine protein-1 levels before and after parathyroidectomy in patients with primary hyperparathyroidism. Endocrine Practice. 2014;20(11):1165-1169]'},{id:"B56",body:'[Silverberg SJ, Clarke BL, Peacock M, Bandeira F, Boutroy S, Cusano NE, et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: Proceedings of the Fourth International Workshop. The Journal of Clinical Endocrinology and Metabolism. 2014;99(10):3580-3594]'},{id:"B57",body:'[Zhao L, Liu J-M, He X-Y, Zhao H-Y, Sun L-H, Tao B, et al. The changing clinical patterns of primary hyperparathyroidism in Chinese patients: Data from 2000 to 2010 in a single clinical center. The Journal of Clinical Endocrinology and Metabolism. 2013;98(2):721-728]'},{id:"B58",body:'[Bandeira F, Cusano NE, Silva BC, Cassibba S, Almeida CB, Machado VCC, et al. Bone disease in primary hyperparathyroidism. Arquivos Brasileiros de Endocrinologia e Metabologia. 2014;58(5):553-561]'},{id:"B59",body:'[Bandeira F, Griz L, Caldas G, Bandeira C, Freese E. From mild to severe primary hyperparathyroidism: The Brazilian experience. Arquivos Brasileiros de Endocrinologia e Metabologia. 2006;50(4):657-663]'},{id:"B60",body:'[Brasier AR, Nussbaum SR. Hungry bone syndrome: Clinical and biochemical predictors of its occurrence after parathyroid surgery. The American Journal of Medicine. 1988;84(4):654-660]'},{id:"B61",body:'[Komaba H, Kakuta T, Fukagawa M. Management of secondary hyperparathyroidism: How and why? Clinical and Experimental Nephrology. 2017;21(S1):37-45]'},{id:"B62",body:'[Vu TDT, Wang XF, Wang Q, Cusano NE, Irani D, Silva BC, et al. New insights into the effects of primary hyperparathyroidism on the cortical and trabecular compartments of bone. Bone. 2013;55(1):57-63]'},{id:"B63",body:'[Hansen S, Beck Jensen J-E, Rasmussen L, Hauge EM, Brixen K. Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: A case-control study using HR-pQCT. Journal of Bone and Mineral Research. 2010;25(9):1941-1947]'},{id:"B64",body:'[Stein EM, Silva BC, Boutroy S, Zhou B, Wang J, Udesky J, et al. Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women. Journal of Bone and Mineral Research. 2013;28(5):1029-1040]'},{id:"B65",body:'[Roux JP, Wegrzyn J, Boutroy S, Bouxsein ML, Hans D, Chapurlat R. The predictive value of trabecular bone score (TBS) on whole lumbar vertebrae mechanics: An ex vivo study. Osteoporosis International. 2013;24(9):2455-2460]'},{id:"B66",body:'[Hans D, Barthe N, Boutroy S, Pothuaud L, Winzenrieth R, Krieg M-A. Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: An experimental study on human cadaver vertebrae. Journal of Clinical Densitometry. 2011;14(3):302-312]'},{id:"B67",body:'[Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, et al. Trabecular bone score: A noninvasive analytical method based upon the DXA image. Journal of Bone and Mineral Research. 2014;29(3):518-530]'},{id:"B68",body:'[Moosgaard B, Christensen SE, Vestergaard P, Heickendorff L, Christiansen P, Mosekilde L. Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clinical Endocrinology. 2008;68(5):707-715]'},{id:"B69",body:'[Grey A, Lucas J, Horne A, Gamble G, Davidson JS, Reid IR. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. The Journal of Clinical Endocrinology and Metabolism. 2005;90(4):2122-2126]'},{id:"B70",body:'[Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. The Journal of Clinical Endocrinology and Metabolism. 2008;93(9):3462-3470]'},{id:"B71",body:'[Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. The New England Journal of Medicine. 1999;341(17):1249-1255]'},{id:"B72",body:'[Vestergaard P, Mollerup CL, Frøkjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L. Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ. 2000;321(7261):598-602]'},{id:"B73",body:'[Khosla S, Melton LJ, Wermers RA, Crowson CS, O’Fallon WM, Riggs BL. Primary hyperparathyroidism and the risk of fracture: A population-based study. Journal of Bone and Mineral Research. 1999;14(10):1700-1707]'},{id:"B74",body:'[Romagnoli E, Cipriani C, Nofroni I, Castro C, Angelozzi M, Scarpiello A, et al. “Trabecular bone score” (TBS): An indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism. Bone. 2013;53(1):154-159]'},{id:"B75",body:'[Eller-Vainicher C, Filopanti M, Palmieri S, Ulivieri FM, Morelli V, Zhukouskaya VV, et al. Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism. European Journal of Endocrinology. 2013;169(2):155-162]'},{id:"B76",body:'[Rao DS, Phillips ER, Divine GW, Talpos GB. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism. 2004;89(11):5415-5422]'},{id:"B77",body:'[Hansen S, Hauge EM, Rasmussen L, Jensen J-EB, Brixen K. Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: A one-year prospective controlled study using high-resolution peripheral quantitative computed tomography. Journal of Bone and Mineral Research. 2012;27(5):1150-1158]'},{id:"B78",body:'[Silverberg SJ, Bilezikian JP. “Incipient” primary hyperparathyroidism: A “forme fruste” of an old disease. The Journal of Clinical Endocrinology and Metabolism. 2003;88(11):5348-5352]'},{id:"B79",body:'[Maruani G, Hertig A, Paillard M, Houillier P. Normocalcemic primary hyperparathyroidism: Evidence for a generalized target-tissue resistance to parathyroid hormone. The Journal of Clinical Endocrinology and Metabolism. 2003;88(10):4641-4648]'},{id:"B80",body:'[Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism: Further characterization of a new clinical phenotype. The Journal of Clinical Endocrinology and Metabolism. 2007;92(8):3001-3005]'},{id:"B81",body:'[Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the Fourth International Workshop. The Journal of Clinical Endocrinology and Metabolism. 2014;99(10):3561-3569]'},{id:"B82",body:'[Bollerslev J, Jansson S, Mollerup CL, Nordenström J, Lundgren E, Tørring O, et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: A prospective, randomized trial. The Journal of Clinical Endocrinology and Metabolism. 2007;92(5):1687-1692]'},{id:"B83",body:'[Christiansen P, Steiniche T, Brixen K, Hessov I, Melsen F, Heickendorff L, et al. Primary hyperparathyroidism: Short-term changes in bone remodeling and bone mineral density following parathyroidectomy. Bone. 1999;25(2):237-244]'},{id:"B84",body:'[Lee JH, Kim JH, Hong AR, Kim SW, Shin CS. Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism. Osteoporosis International. 2017;28(5):1667-1674]'},{id:"B85",body:'[Yeh MW, Zhou H, Adams AL, Ituarte PHG, Li N, Liu I-LA, et al. The relationship of parathyroidectomy and bisphosphonates with fracture risk in primary hyperparathyroidism: An observational study. Annals of Internal Medicine. 2016;164(11):715-723]'},{id:"B86",body:'[Rudser KD, de Boer IH, Dooley A, Young B, Kestenbaum B. Fracture risk after parathyroidectomy among chronic hemodialysis patients. Journal of the American Society of Nephrology. 2007;18(8):2401-2407]'},{id:"B87",body:'[Khan AA, Bilezikian JP, Kung AWC, Ahmed MM, Dubois SJ, Ho AYY, et al. Alendronate in primary hyperparathyroidism: A double-blind, randomized, placebo-controlled trial. The Journal of Clinical Endocrinology and Metabolism. 2004;89(7):3319-3325]'},{id:"B88",body:'[Khan A, Bilezikian J, Kung A, Dubois S, Standish T, Syed Z. Alendronate therapy in men with primary hyperparathyroidism. Endocrine Practice. 2009;15(7):705-713]'},{id:"B89",body:'[Cesareo R, Di Stasio E, Vescini F, Campagna G, Cianni R, Pasqualini V, et al. Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism. Osteoporosis International. 2015;26(4):1295-1302]'},{id:"B90",body:'[Parker CR, Blackwell PJ, Fairbairn KJ, Hosking DJ. Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: A 2-year study. The Journal of Clinical Endocrinology and Metabolism. 2002;87(10):4482-4489]'},{id:"B91",body:'[Akbaba G, Isik S, Ates Tutuncu Y, Ozuguz U, Berker D, Guler S. Comparison of alendronate and raloxifene for the management of primary hyperparathyroidism. Journal of Endocrinological Investigation. 2013;36(11):1076-1082]'},{id:"B92",body:'[Chow CC, Chan WB, Li JKY, Chan NN, Chan MHM, Ko GTC, et al. Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism. 2003;88(2):581-587]'},{id:"B93",body:'[Adami S, Mian M, Bertoldo F, Rossini M, Jayawerra P, O’Riordan JL, et al. Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: Effects of bisphosphonate treatment. Clinical Endocrinology. 1990;33(3):391-397]'},{id:"B94",body:'[Phitayakorn R, McHenry CR. Hyperparathyroid crisis: Use of bisphosphonates as a bridge to parathyroidectomy. Journal of the American College of Surgeons. 2008;206(6):1106-1115]'},{id:"B95",body:'[Jansson S, Morgan E. Biochemical effects from treatment with bisphosphonate and surgery in patients with primary hyperparathyroidism. World Journal of Surgery. 2004;28(12):1293-1297]'},{id:"B96",body:'[Ammann P, Herter-Clavel C, Lubrano A, Rizzoli R. A single bisphosphonate infusion is associated with improved functional capacity in elderly subjects with primary hyperparathyroidism. Aging Clinical and Experimental Research. 2003;15(6):500-504]'},{id:"B97",body:'[Schmidli RS, Wilson I, Espiner EA, Richards AM, Donald RA. Aminopropylidine diphosphonate (APD) in mild primary hyperparathyroidism: Effect on clinical status. Clinical Endocrinology. 1990;32(3):293-300]'},{id:"B98",body:'[Ishimura E, Miki T, Koyama H, Harada K, Nakatsuka K, Inaba M, et al. Effect of aminohydroxypropylidene diphosphonate on the bone metabolism of patients with parathyroid adenoma. Hormone and Metabolic Research. 1993;25(9):493-497]'},{id:"B99",body:'[Jansson S, Tisell LE, Lindstedt G, Lundberg PA. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism. Surgery. 1991;110(3):480-486]'},{id:"B100",body:'[van Breukelen FJ, Bijvoet OL, Frijlink WB, Sleeboom HP, Mulder H, van Oosterom AT. Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: Observations on regulation of serum calcium. Calcified Tissue International. 1982;34(4):321-327]'},{id:"B101",body:'[Hamdy NA, Gray RE, McCloskey E, Galloway J, Rattenbury JM, Brown CB, et al. Clodronate in the medical management of hyperparathyroidism. Bone. 1987;8(Suppl 1):S69-S77]'},{id:"B102",body:'[Douglas DL, Kanis JA, Paterson AD, Beard DJ, Cameron EC, Watson ME, et al. Drug treatment of primary hyperparathyroidism: Use of clodronate disodium. British Medical Journal (Clinical Research Ed.). 1983;286(6365):587-590]'},{id:"B103",body:'[Shane E, Baquiran DC, Bilezikian JP. Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism. Annals of Internal Medicine. 1981;95(1):23-27]'},{id:"B104",body:'[Tournis S, Fakidari E, Dontas I, Liakou C, Antoniou J, Galanos A, et al. Effect of parathyroidectomy versus risedronate on volumetric bone mineral density and bone geometry at the tibia in postmenopausal women with primary hyperparathyroidism. Journal of Bone and Mineral Metabolism. 2014;32(2):151-158]'},{id:"B105",body:'[Reasner CA, Stone MD, Hosking DJ, Ballah A, Mundy GR. Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate. The Journal of Clinical Endocrinology and Metabolism. 1993;77(4):1067-1071]'},{id:"B106",body:'[Segula D, Nikolova T, Marks E, Ranganath L, Mishra V. Long term outcome of bisphosphonate therapy in patients with primary hyperparathyroidism. International Journal of Clinical Medicine. 2014;5(14):829-835]'},{id:"B107",body:'[Nemeth EF, Heaton WH, Miller M, Fox J, Balandrin MF, Van Wagenen BC, et al. Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. The Journal of Pharmacology and Experimental Therapeutics. 2004;308(2):627-635]'},{id:"B108",body:'[Faggiano A, Di Somma C, Ramundo V, Severino R, Vuolo L, Coppola A, et al. Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism. Endocrine. 2011;39(3):283-287]'},{id:"B109",body:'[Cetani F, Saponaro F, Banti C, Cianferotti L, Vignali E, Chiavistelli S, et al. Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European medicine agency prescription labeling. Journal of Endocrinological Investigation. 2012;35(7):655-660]'},{id:"B110",body:'[Giusti F, Cianferotti L, Gronchi G, Cioppi F, Masi L, Faggiano A, et al. Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to multiple endocrine neoplasia syndrome type 1 (MEN1). Endocrine. 2016;52(3):495-506]'},{id:"B111",body:'[Peacock M, Bilezikian JP, Klassen PS, Guo MD, Turner SA, Shoback D. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism. 2005;90(1):135-141]'},{id:"B112",body:'[Peacock M, Bolognese MA, Borofsky M, Scumpia S, Sterling LR, Cheng S, et al. Cinacalcet treatment of primary hyperparathyroidism: Biochemical and bone densitometric outcomes in a five-year study. The Journal of Clinical Endocrinology and Metabolism. 2009;94(12):4860-4867]'},{id:"B113",body:'[Keutgen XM, Buitrago D, Filicori F, Kundel A, Elemento O, Fahey TJ, et al. Calcimimetics versus parathyroidectomy for treatment of primary hyperparathyroidism: Retrospective chart analysis of a prospective database. Annals of Surgery. 2012;255(5):981-985]'},{id:"B114",body:'[Norman J, Lopez J, Politz D. Cinacalcet (Sensipar) provides no measurable clinical benefits for patients with primary hyperparathyroidism and may accelerate bone loss with prolonged use. Annals of Surgical Oncology. 2012;19(5):1466-1471]'},{id:"B115",body:'[Stein EM, Dempster DW, Udesky J, Zhou H, Bilezikian JP, Shane E, et al. Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism. Bone. 2011;48(3):557-561]'},{id:"B116",body:'[Jorde R, Szumlas K, Haug E, Sundsfjord J. The effects of calcium supplementation to patients with primary hyperparathyroidism and a low calcium intake. European Journal of Nutrition. 2002;41(6):258-263]'},{id:"B117",body:'[Rolighed L, Bollerslev J, Mosekilde L. Vitamin D treatment in primary hyperparathyroidism. Current Drug Safety. 2011;6(2):100-107]'},{id:"B118",body:'[Walker MD, Cong E, Lee JA, Kepley A, Zhang C, McMahon DJ, et al. Vitamin D in primary hyperparathyroidism: Effects on clinical, biochemical, and densitometric presentation. The Journal of Clinical Endocrinology and Metabolism. 2015;100(9):3443-3451]'},{id:"B119",body:'[Bollerslev J, Marcocci C, Sosa M, Nordenström J, Bouillon R, Mosekilde L. Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. European Journal of Endocrinology. 2011;165(6):851-864]'},{id:"B120",body:'[Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, et al. Primary hyperparathyroidism: Review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporosis International. 2017;28(1):1-19]'},{id:"B121",body:'[Grey AB, Stapleton JP, Evans MC, Tatnell MA, Reid IR. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial. Annals of Internal Medicine. 1996;125(5):360-368]'},{id:"B122",body:'[Selby PL, Peacock M. Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women. The New England Journal of Medicine. 1986;314(23):1481-1485]'},{id:"B123",body:'[Zanchetta JR, Bogado CE. Raloxifene reverses bone loss in postmenopausal women with mild asymptomatic primary hyperparathyroidism. Journal of Bone and Mineral Research. 2001;16(1):189-190]'},{id:"B124",body:'[Rubin MR, Lee KH, McMahon DJ, Silverberg SJ. Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism. 2003;88(3):1174-1178]'},{id:"B125",body:'[Schieferdecker A, Voigt M, Riecken K, Braig F, Schinke T, Loges S, et al. Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL. Oncotarget. 2014;5(16):6647-6653]'}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Ahmed Khedr",address:"ahmedkhedr@kasralainy.edu.eg",affiliation:'- Department of Orthopedic Surgery, University of Pittsburgh, USA
- Department of Orthopedic Surgery, Faculty of Medicine, Cairo University, Egypt
'}],corrections:null},book:{id:"6342",title:"Anatomy, Posture, Prevalence, Pain, Treatment and Interventions of Musculoskeletal Disorders",subtitle:null,fullTitle:"Anatomy, Posture, Prevalence, Pain, Treatment and Interventions of Musculoskeletal Disorders",slug:"anatomy-posture-prevalence-pain-treatment-and-interventions-of-musculoskeletal-disorders",publishedDate:"June 6th 2018",bookSignature:"Orhan Korhan",coverURL:"https://cdn.intechopen.com/books/images_new/6342.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"101698",title:"Dr.",name:"Orhan",middleName:null,surname:"Korhan",slug:"orhan-korhan",fullName:"Orhan Korhan"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"57924",title:"Muscle Pain and Muscle Spindles",slug:"muscle-pain-and-muscle-spindles",totalDownloads:568,totalCrossrefCites:0,signatures:"Juhani V. Partanen",authors:[{id:"215350",title:"Dr.",name:"Juhani",middleName:null,surname:"Partanen",fullName:"Juhani Partanen",slug:"juhani-partanen"}]},{id:"57747",title:"Objective analysis for evaluation the stress of the hand",slug:"objective-analysis-for-evaluation-the-stress-of-the-hand",totalDownloads:581,totalCrossrefCites:0,signatures:"Aydin Ünlü, Peter Gust and Frank Mersch",authors:[{id:"215892",title:"Dr.",name:"Aydin",middleName:null,surname:"Ünlü",fullName:"Aydin Ünlü",slug:"aydin-unlu"},{id:"216252",title:"MSc.",name:"Frank",middleName:null,surname:"Mersch",fullName:"Frank Mersch",slug:"frank-mersch"},{id:"216253",title:"Prof.",name:"Peter",middleName:null,surname:"Gust",fullName:"Peter Gust",slug:"peter-gust"}]},{id:"58327",title:"Ergonomic Interventions for the Prevention of Musculoskeletal Disorders",slug:"ergonomic-interventions-for-the-prevention-of-musculoskeletal-disorders",totalDownloads:527,totalCrossrefCites:0,signatures:"Theresa Stack",authors:[{id:"213698",title:"Associate Prof.",name:"Theresa",middleName:null,surname:"Stack",fullName:"Theresa Stack",slug:"theresa-stack"}]},{id:"57980",title:"Ergonomics Education for Office Computer Workers: An Evidence-Based Strategy",slug:"ergonomics-education-for-office-computer-workers-an-evidence-based-strategy",totalDownloads:1143,totalCrossrefCites:0,signatures:"Karthik Mani",authors:[{id:"212310",title:"Dr.",name:"Karthik",middleName:null,surname:"Mani",fullName:"Karthik Mani",slug:"karthik-mani"}]},{id:"59630",title:"Joint Instability as the Cause of Chronic Musculoskeletal Pain and Its Successful Treatment with Prolotherapy",slug:"joint-instability-as-the-cause-of-chronic-musculoskeletal-pain-and-its-successful-treatment-with-pro",totalDownloads:655,totalCrossrefCites:1,signatures:"Ross A. Hauser and Barbara A. Woldin",authors:[{id:"213190",title:"M.D.",name:"Ross",middleName:null,surname:"Hauser",fullName:"Ross Hauser",slug:"ross-hauser"},{id:"213191",title:"Ms.",name:"Barbara",middleName:null,surname:"Woldin",fullName:"Barbara Woldin",slug:"barbara-woldin"}]},{id:"59334",title:"Skeletal Manifestations of Hyperparathyroidism",slug:"skeletal-manifestations-of-hyperparathyroidism",totalDownloads:556,totalCrossrefCites:0,signatures:"Ahmed Khedr",authors:[{id:"221546",title:"Dr.",name:"Ahmed",middleName:null,surname:"Khedr",fullName:"Ahmed Khedr",slug:"ahmed-khedr"}]},{id:"60769",title:"SAPHO Syndrome",slug:"sapho-syndrome",totalDownloads:377,totalCrossrefCites:0,signatures:"José Ángel López Díaz, Luis Geniz Rubio and Sara Alcántara Luna",authors:[{id:"211767",title:"Dr.",name:"Sara",middleName:null,surname:"Alcantara",fullName:"Sara Alcantara",slug:"sara-alcantara"},{id:"217054",title:"Dr.",name:"Luis",middleName:null,surname:"Geniz Rubio",fullName:"Luis Geniz Rubio",slug:"luis-geniz-rubio"},{id:"217165",title:"Dr.",name:"Jose Angel",middleName:null,surname:"Lopez",fullName:"Jose Angel Lopez",slug:"jose-angel-lopez"}]}]},relatedBooks:[{type:"book",id:"5528",title:"Occupational Health",subtitle:null,isOpenForSubmission:!1,hash:"44af436d1ad45d04f2ed69d5eae1ba4c",slug:"occupational-health",bookSignature:"Orhan Korhan",coverURL:"https://cdn.intechopen.com/books/images_new/5528.jpg",editedByType:"Edited by",editors:[{id:"101698",title:"Dr.",name:"Orhan",surname:"Korhan",slug:"orhan-korhan",fullName:"Orhan Korhan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"53383",title:"New Paradigms in Ergonomics: The Positive Ergonomics",slug:"new-paradigms-in-ergonomics-the-positive-ergonomics",signatures:"Mohamed Mokdad and Tawfik Abdel-Moniem",authors:[{id:"104865",title:"Prof.",name:"Mohamed",middleName:null,surname:"Mokdad",fullName:"Mohamed Mokdad",slug:"mohamed-mokdad"},{id:"194579",title:"Prof.",name:"Tawfik",middleName:null,surname:"Abdel Moniem",fullName:"Tawfik Abdel Moniem",slug:"tawfik-abdel-moniem"}]},{id:"53519",title:"Understanding the Stakeholders as a Success Factor for Effective Occupational Health Care",slug:"understanding-the-stakeholders-as-a-success-factor-for-effective-occupational-health-care",signatures:"Ari-Matti Auvinen",authors:[{id:"193252",title:"M.A.",name:"Ari-Matti",middleName:null,surname:"Auvinen",fullName:"Ari-Matti Auvinen",slug:"ari-matti-auvinen"}]},{id:"53716",title:"Occupational Risks of Health Professionals",slug:"occupational-risks-of-health-professionals",signatures:"Nilgun Ulutasdemir and Ferdi Tanir",authors:[{id:"191796",title:"Associate Prof.",name:"Nilgun",middleName:null,surname:"Ulutasdemir",fullName:"Nilgun Ulutasdemir",slug:"nilgun-ulutasdemir"},{id:"195566",title:"Prof.",name:"Ferdi",middleName:null,surname:"Tanır",fullName:"Ferdi Tanır",slug:"ferdi-tanir"}]},{id:"53481",title:"HSE Management for a Sound Work Environment: Strategies for Improving Health Safety and Environmental Indicators through Ergonomic Design Thinking",slug:"hse-management-for-a-sound-work-environment-strategies-for-improving-health-safety-and-environmental",signatures:"Marcello Silva e Santos, Maria da Conceição Vinciprova Fonseca,\nMarcelo Marcio Soares, Bernardo Bastos da Fonseca, Maria Victoria\nCabrera Aguilera and Ananda Halfeld Alves Fernandes",authors:[{id:"192187",title:"Dr.",name:"Marcello",middleName:"Silvae",surname:"Santos",fullName:"Marcello Santos",slug:"marcello-santos"},{id:"199211",title:"Dr.",name:"Bernardo",middleName:null,surname:"Bastos da Fonseca",fullName:"Bernardo Bastos da Fonseca",slug:"bernardo-bastos-da-fonseca"}]},{id:"52643",title:"Health‐Promoting Leadership Culture and its Role in Workplace Health Promotion",slug:"health-promoting-leadership-culture-and-its-role-in-workplace-health-promotion",signatures:"Simona Šarotar Žižek, Matjaž Mulej and Vesna Čančer",authors:[{id:"192730",title:"Associate Prof.",name:"Simona",middleName:null,surname:"Šarotar Žižek",fullName:"Simona Šarotar Žižek",slug:"simona-sarotar-zizek"}]},{id:"53282",title:"Is Insulin Resistance Work Related?",slug:"is-insulin-resistance-work-related-",signatures:"Marina Oțelea",authors:[{id:"191905",title:"Dr.",name:"Marina",middleName:null,surname:"Otelea",fullName:"Marina Otelea",slug:"marina-otelea"}]},{id:"52841",title:"Epidemiology of Needlestick and Sharps Injuries in Veterinary Medicine",slug:"epidemiology-of-needlestick-and-sharps-injuries-in-veterinary-medicine",signatures:"Ana Cláudia Coelho",authors:[{id:"79219",title:"Prof.",name:"Ana Cláudia",middleName:null,surname:"Coelho",fullName:"Ana Cláudia Coelho",slug:"ana-claudia-coelho"}]},{id:"52842",title:"Gene-Environment Interactions: The Case of Asbestosis",slug:"gene-environment-interactions-the-case-of-asbestosis",signatures:"Vita Dolzan, Metoda Dodic-Fikfak and Alenka Franko",authors:[{id:"60449",title:"Prof.",name:"Vita",middleName:null,surname:"Dolžan",fullName:"Vita Dolžan",slug:"vita-dolzan"},{id:"195632",title:"Prof.",name:"Alenka",middleName:null,surname:"Franko",fullName:"Alenka Franko",slug:"alenka-franko"},{id:"195633",title:"Prof.",name:"Metoda",middleName:null,surname:"Dodic-Fikfak",fullName:"Metoda Dodic-Fikfak",slug:"metoda-dodic-fikfak"}]},{id:"53365",title:"Ibuprofen as a Treatment for Work-Related Musculoskeletal Disorders: Effectiveness versus Caveats",slug:"ibuprofen-as-a-treatment-for-work-related-musculoskeletal-disorders-effectiveness-versus-caveats",signatures:"Mary F. Barbe and Ann E. Barr-Gillespsie",authors:[{id:"197229",title:"Dr.",name:"Mary F",middleName:null,surname:"Barbe",fullName:"Mary F Barbe",slug:"mary-f-barbe"},{id:"197459",title:"Dr.",name:"Ann",middleName:"E",surname:"Barr-Gillespie",fullName:"Ann Barr-Gillespie",slug:"ann-barr-gillespie"}]},{id:"53587",title:"Work-Related Musculoskeletal Disorders and the Relationship to Ethnicity",slug:"work-related-musculoskeletal-disorders-and-the-relationship-to-ethnicity",signatures:"Rosana M. Quintana",authors:[{id:"193827",title:"Ph.D.",name:"Rosana",middleName:null,surname:"Quintana",fullName:"Rosana Quintana",slug:"rosana-quintana"}]},{id:"52610",title:"Working in Cold Environment: Clothing and Thermophysiological Comfort",slug:"working-in-cold-environment-clothing-and-thermophysiological-comfort",signatures:"Radostina A. Angelova",authors:[{id:"175795",title:"Associate Prof.",name:"Radostina",middleName:"A.",surname:"Angelova",fullName:"Radostina Angelova",slug:"radostina-angelova"}]},{id:"53015",title:"Step-By-Step Procedure and Tools to Reduce Work-Related Stress",slug:"step-by-step-procedure-and-tools-to-reduce-work-related-stress",signatures:"Azra Huršidić Radulović",authors:[{id:"193453",title:"Ph.D.",name:"Azra",middleName:null,surname:"Huršidić Radulović",fullName:"Azra Huršidić Radulović",slug:"azra-hursidic-radulovic"}]}]}]},onlineFirst:{chapter:{type:"chapter",id:"72786",title:"Evaluation of Ornamental Plants for Phytoremediation of Contaminated Soil",doi:"10.5772/intechopen.93163",slug:"evaluation-of-ornamental-plants-for-phytoremediation-of-contaminated-soil",body:'\n\n
1. Introduction
\n
Environmental pollution has been on the rise over the past decades because of the increasing human activities on energy reservoirs, unsafe agricultural practices, and rapid industrialization. The result of these technogenic and anthropogenic activities are the major sources of heavy metals in the environment [1]. In Nigeria, soil contaminations is caused by industrial and agricultural practices such as chemical fertilizer and pesticide application, wastewater irrigation, mining activities, and metal smelting. All these human activities have contributed to problems hindering the nation’s agriculture from attaining food security.
\n
However, agriculture in Nigeria has been facing two challenges for a long time, these challenges are; promoting environmental sustainability and enhancing food production. To ameliorate these challenges, there is a need to adopt management techniques that promote environmental sustainability. Phytoremediation has been identified as a cost-effective and easy way to sustain our environment by removing toxic elements from contaminated soils. Phytoremediation is a technique that relies on the use of plant interactions (physical, biochemical, biological, chemical, and microbiological) in polluted sites to mitigate the toxic effects of pollutants [2]. In Nigeria, heavy metals, pesticides, greenhouse gases, and hydrocarbons are pollutants that are of environmental and public health concerns.
\n
The toxicity of heavy metals in the biota is because of their bioaccumulative nature and persistence in the environment thereby contaminating the food chains. The soil-to-plant transfer of heavy metals made it easy for metal transfer into the food chains. Metals are absorbed by plant roots and transferred to herbivorous animals along the food chain [3]. When plants like vegetables or cereals are planted in contaminated soils, the consumption of such food becomes a serious health issue to man [4].
\n
However, because of the threat posed by the heavy metals on the growth and development of arable crops, scientists have warned against the use of crops as a phytoremediator because of their risk on human health after consumption. This is the reason for the shift to ornamental plants. The use of ornamentals continues to attract attention in recent years. In Nigeria, most ornamentals plants are not edible, therefore, the risk of contaminants entering the food chain is reduced.
\n
The use of ornamental plants as a test plant in a phytoremediation experiment is because of their high biomass which means they can accumulate more heavy-metal concentration through their roots, into their tissues. Many studies have been conducted to evaluate the potentials of ornamental plants as in phytoremediation [5, 6, 7, 8]. However, most of the selected ornamental plants used in all the studies were not indigenous and not commonly cultivated in Nigeria. Therefore, this study aims to evaluate the phytoremediation potential of two ornamental plants in common, although not indigenous in Nigeria. In addition, Codiaeum variegatum and Basella alba were used in this study because they grow well in heavy metal contaminated soils, but their mechanism to resist the heavy metals has not been reported. B. alba belongs to the family of Basellaceae and commonly refers to as Indian spinach, Malabar spinach, Ceylon spinach, and vine spinach. The plant is an underutilized vegetable in Nigeria compare to Amaranthus spp. and Telfairia occidentalis. In addition to being edible, B alba is also grown as an ornamental foliage vine. Codiaeum variegatum is an ornamental plant species that belongs to the genus Codiaeum, and the family Euphorbiaceae.
\n
\n\n
2. Objective
\n
To examine the phytoremediation potential of C. variegatum and B. alba in heavy metal contaminated soils collected from four sites. The study also analyzed part of the plant with higher heavy metal concentration (shoots or roots) and the heavy metal concentration left in the soil after the experiment.
\n
\n\n
3. Materials and methods
\n
A Completely Randomized Design with three replicates was conducted at the Screen house of the Department of Crop Soil and Pest Management, Federal University of Technology Akure, Ondo State located in the rain forest vegetation zone of Nigeria (7°16′N, 5°12′E). Soils were collected from four sites (Mechanic workshop, Dumpsite, Forest topsoil, and Effluent site) and filled into the buckets and transported to the screen house. The soils from the four locations served as the treatments. A total of 12 plastic buckets were used for each ornamental plant (4 locations replicated three times), to make it 24 plastic buckets for both ornamental plants (C. variegatum and B. alba). The planting material was obtained from LUCADO horticultural garden located in Akure (less than 5 km to the experimental site). The seeds of B. alba were planted while the seedlings of C. variegatum were purchased from the horticultural garden and it was repotted. Watering was done daily and weeds were hand-pulled.
\n
Initial soil analysis was conducted on all the soils to determine heavy metal concentration. The heavy metal tested on soil and plant samples were, Cu, Cd, Ni, Pb, and Zn using Atomic Absorption Spectrometer [9]. The plant growth traits were recording, including; plant height (cm), stem girth (cm), leaf length (cm) and leaf numbers. At 12 weeks after planting (WAP), soil analysis was done to determine the remaining heavy metal concentration in the soil in order to determine the percentage of contamination reduction. In the final week of the experiment (12 weeks after planting), soil and plant (root and shoot) samples were again analyzed to determine the heavy metal concentration. WHO [10] permissible limit for heavy metal concentration in the soil and plant were used as standard and as a rating for each plant phytoremediation potential. The data were subjected to analysis of variance (ANOVA) using Statistical Package for Social Sciences (Version 17). Significant means were from each other using Tukey Test at 5% level of probability.
\n
\n\n
4. Results and discussion
\n
\n
4.1 Effect of heavy metal on plant growth parameters
\n
Significant differences were recorded across the treatments (soils from different locations) for the growth parameters of C. variegatum (Table 1). There was no consistency in the growth performance as severe impact was felt on the number of leaves, stem girth, and leaf length of C. variegatum planted in soils from the effluent site as they had the least mean value. C. variegatum planted in soils collected from dumpsite had the highest mean value for number of leaves, stem girth, and leaf length. The severe impact felt on C. variegatum planted on the effluent site could be attributed to excess levels of metals which may have inhibits physiologically active enzymes as earlier speculated by Gadd [11]. Significant differences were recorded across the treatments for the growth parameters of B. alba (Table 1). The results revealed that B. alba planted in soils from dumpsite and forest topsoil gave the highest mean value for plant height, number of leaves, and leaf length. Plants on the two soils appeared healthy because the forest topsoils served as the control. The good performance of B. alba planted on the dumpsite soils could be a result of a high level of organic matter content.
\n
\n\n\n\n\n\n\n\nTreatments | \nPlant height | \nNumber of leaves | \nStem girth | \nLeaf length | \n
\n\n\n\n\nC. variegatum\n | \n
\n\nMS | \n11.88a | \n10.00ab | \n0.79a | \n23.72c | \n
\n\nES | \n15.10c | \n8.00a | \n0.75a | \n19.27a | \n
\n\nDS | \n14.36b | \n17.00c | \n0.96b | \n24.02d | \n
\n\nFS | \n13.83b | \n10.00ab | \n0.89ab | \n21.68b | \n
\n\n\nB. alba\n | \n
\n\nMS | \n21.96a | \n10.45a | \n0.51a | \n10.14a | \n
\n\nES | \n30.78b | \n15.17c | \n0.62a | \n10.08a | \n
\n\nDS | \n60.19c | \n15.00c | \n0.72a | \n12.89b | \n
\n\nFS | \n65.55d | \n14.00bc | \n0.66a | \n11.23ab | \n
\n\n
Table 1.
Effect of soil from different sites on growth parameters of the ornamental plants.
Means with the same letter in the same column are not significantly different from one another at p < 0.05 based Duncan test.
MS—soils from mechanic workshop; ES—effluent site; DS—dumpsite; FS—forest topsoil.
\n
\n\n\n\n\n\nHeavy metals | \nTarget value of soil (mg/kg) | \nPermissible value of Plant (mg/kg) | \n
\n\n\n\nCu | \n36 | \n10 | \n
\n\nCd | \n0.8 | \n0.02 | \n
\n\nNi | \n35 | \n10 | \n
\n\nPb | \n85 | \n2 | \n
\n\nZn | \n50 | \n0.60 | \n
\n\n
Table 2.
WHO permissible limit of Cu, Cd, Ni, Pb and Zn in soil and plant by WHO [10].
Target values are specified to indicate desirable maximum levels of elements in unpolluted soils.
Source: WHO [10].
\n
\n
\n
4.2 Initial and final metal concentrations in plant tissues and in soils
\n
The result presented in Table 3 shows the initial concentration of heavy metals in the root and shoot of C. variegatum and B. alba. The concentration of the heavy metals present in the plant was within the permissible value recommended by the WHO (Table 2) for except for the Zn concentration (in both plants), and Cd (B. alba only). The initial Zn concentration present in root part of B. alba was above the minimum plant permissible limit (3.056 mg/kg) while the concentration present at the shoot part was below the permissible limit (0.421 mg/kg).
\n
\n\n\n\n\n\n\n\nHeavy metals | \n\nB. alba\n | \n\nC. variegatum\n | \n
\n\n | \nRoot | \nShoot | \nRoot | \nShoot | \n
\n\n\n\nCu | \n0.455 | \n0.193 | \n0.572 | \n0.49 | \n
\n\nCd | \n0.054 | \n0.01 | \n0.01 | \nBDL | \n
\n\nNi | \n0.082 | \n0.027 | \n0.09 | \n0.01 | \n
\n\nPb | \n0.034 | \nBDL | \n0.032 | \nBDL | \n
\n\nZn | \n3.056 | \n0.421 | \n3.25 | \n2.081 | \n
\n\n
Table 3.
Initial analysis to determine heavy metal conc. in plant root and shoot (ppm).
BDL = Below Instrument Detection Limit (<0.001 ppm) *1 mg/kg = 1 ppm.
MS—soils from mechanic workshop; ES—effluent site; DS—dumpsite; FS—forest topsoil.
\n
The result presented in Table 4 shows the initial and final heavy metal concentration of soils from the four sources. The results revealed that the initial and final heavy metal concentrations in all the soils were below the target value recommended by WHO for soils. However, soils from the mechanic workshop site show a considerable decrease in the heavy metal concentration present at the end of the experiment. The initial Pb concentration for the soil was 0.215 but was reduced to 0.093 in the pot where B. alba was planted while it was absorbed below the detective limit by C. variegatum. A similar trend was also observed for soils collected from an effluent and dumpsite site for all the heavy metals measured. However, there was a slight change in this trend for soils collected from forest topsoil, as there was a slight increase in the final heavy metal concentration recorded for metals such as Cu (initial 0.751; final 0.892 B. alba, 1.073 C. variegatum), Cd (initial 0.072; final 0.097, B. alba), and Zn (initial 27.525; final 27.095 B. alba 28.1 C. variegatum).\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n
\n\n\n\n\n\n\nSoil source | \nInitial | \nFinal Conc. | \n
\n\n | \n | \n\nB. alba\n | \n\nC. variegatum\n | \n
\n\n\n\nMechanic | \n
\n\nCu | \n1.567 | \n0.836 | \n1.484 | \n
\n\nCd | \n0.11 | \n0.088 | \n0.085 | \n
\n\nNi | \n0.89 | \n0.26 | \n0.314 | \n
\n\nPb | \n0.215 | \n0.093 | \nBDL | \n
\n\nZn | \n37.17 | \n24.9 | \n31.274 | \n
\n\nEffluent | \n
\n\nCu | \n2.122 | \n1.75 | \n1.823 | \n
\n\nCd | \n0.153 | \n0.11 | \n0.142 | \n
\n\nNi | \n1.27 | \n0.494 | \n0.829 | \n
\n\nPb | \n0.262 | \n0.21 | \n0.069 | \n
\n\nZn | \n42.57 | \n26.35 | \n32.923 | \n
\n\nDumpsite | \n
\n\nCu | \n2.014 | \n0.962 | \n1.216 | \n
\n\nCd | \n0.289 | \n0.068 | \n0.092 | \n
\n\nNi | \n1.276 | \n0.398 | \n0.483 | \n
\n\nPb | \n0.312 | \nBDL | \n0.077 | \n
\n\nZn | \n32.036 | \n28.719 | \n30.136 | \n
\n\nForest topsoil | \n
\n\nCu | \n0.751 | \n0.892 | \n1.073 | \n
\n\nCd | \n0.072 | \n0.097 | \n0.047 | \n
\n\nNi | \n0.558 | \n0.085 | \n0.048 | \n
\n\nPb | \n0.134 | \n0.145 | \n0.066 | \n
\n\nZn | \n27.525 | \n27.095 | \n28.1 | \n
\n\n
Table 4.
Soil heavy metal concentration (mg/kg).
BDL = Below Instrument Detection Limit (< 0.001 ppm) *1 mg/kg = 1 ppm.
MS—soils from mechanic workshop; ES—effluent site; DS—dumpsite; FS—forest topsoil.
\n
Result presented in Table 5 shows the final heavy metal concentration present in the plant parts for all the soils. For soils collected from the mechanic workshop, the Cd (0.06 for B. alba and C. variegatum) and Zn concentration present in both plants were above the WHO permissible limit, while the remaining metals were within the permissible limit. Similar trends or results were also recorded for soils collected from the effluent site, dumpsite, and forest topsoil. The growth of both plants were affected variably by the stress of heavy metals such as Zn and Cd. High concentrations of Zn and Cd resulted in stunted growth, reduced biomass production and produced characteristic visible effects similar to those described by other workers in different plant species [12, 13]. These observations are substantiated by a significant concentration in the level of Zn and Cd present in the plant tissue of both ornamental plants. The decrease in the mean value of growth parameters of B. alba and C. variegatum planted on soils from effluents and mechanic site may be attributed to the significantly high concentration of Cd and Zn value which is higher than the permissible limit. These findings agree with Pandey and Pathak [14]. Metal stress in plants leads to a decrease in growth parameters and dry matter of plants [14, 15].
\n
\n\n\n\n\n\n\n\n | \n\nB. alba\n | \n\nC. variegatum\n | \n
\n\n | \nRoot | \nShoot | \nRoot | \nShoot | \n
\n\n\n\nMechanic | \n
\n\nCu | \n0.627 | \n0.038 | \n0.915 | \n0.085 | \n
\n\nCd | \n0.049 | \n0.012 | \n0.049 | \n0.011 | \n
\n\nNi | \n0.078 | \n0.031 | \n0.079 | \n0.011 | \n
\n\nPb | \n0.011 | \nBDL | \nBDL | \nBDL | \n
\n\nZn | \n3.038 | \n0.32 | \n3.063 | \n0.475 | \n
\n\nEffluent | \n
\n\nCu | \n0.484 | \n0.041 | \n0.915 | \n0.059 | \n
\n\nCd | \n0.037 | \n0.01 | \n0.051 | \nBDL | \n
\n\nNi | \n0.087 | \n0.03 | \n0.065 | \n0.02 | \n
\n\nPb | \nBDL | \nBDL | \n0.017 | \nBDL | \n
\n\nZn | \n2.737 | \n0.299 | \n2.873 | \n0.628 | \n
\n\nDumpsite | \n
\n\nCu | \n1.096 | \n0.12 | \n0.838 | \n0.514 | \n
\n\nCd | \n0.052 | \n0.013 | \n0.024 | \n0.01 | \n
\n\nNi | \n0.07 | \n0.025 | \n0.085 | \n0.026 | \n
\n\nPb | \n0.015 | \n0.01 | \n0.02 | \n0.01 | \n
\n\nZn | \n3.173 | \n0.125 | \n2.955 | \n0.315 | \n
\n\nForest topsoil | \n
\n\nCu | \n0.537 | \n0.3 | \n0.563 | \n0.05 | \n
\n\nCd | \n0.057 | \n0.021 | \n0.023 | \nBDL | \n
\n\nNi | \n0.092 | \n0.04 | \n0.06 | \nBDL | \n
\n\nPb | \n0.009 | \n0.003 | \nBDL | \nBDL | \n
\n\nZn | \n2.859 | \n0.538 | \n3.425 | \n0.211 | \n
\n\n
Table 5.
Concentration of heavy metals in plants part soil source.
BDL = Below Instrument Detection Limit (<0.001 ppm)*1 mg/kg = 1 ppm.
MS—soils from mechanic workshop; ES—effluent site; DS—dumpsite; FS—forest topsoil.
\n
\n
\n\n
5. Conclusion
\n
This study was conducted to determine the phytoremediation potential of two ornamental plants (B. alba and C. variegatum). The study reveals the ability of both plants in removing heavy metals (hyperaccumulators), but most heavy concentration was accumulated in the roots more than shoots. However, the accumulation of Cd and Zn at the end of the study was higher than the permissible limit. However, the use of B. alba to remediate the soil may not be advisable because of its less phytoremediation potential compare to C. variegatum. Also the former is edible and could pose a serious threat to health when consumed. Finally, additional studies are needed to investigate the phytoremediation performance of more indigenous ornamental plants in Nigeria.
\n
\n\n',keywords:"ornamental plants, metals, toxics, phytoremediation",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/72786.pdf",chapterXML:"https://mts.intechopen.com/source/xml/72786.xml",downloadPdfUrl:"/chapter/pdf-download/72786",previewPdfUrl:"/chapter/pdf-preview/72786",totalDownloads:40,totalViews:0,totalCrossrefCites:0,dateSubmitted:"May 30th 2020",dateReviewed:"June 12th 2020",datePrePublished:"February 9th 2021",datePublished:null,dateFinished:"July 11th 2020",readingETA:"0",abstract:"A completely randomized design with three replicates was conducted at the Screen house of the Department of Crop Soil and Pest Management, Federal University of Technology Akure, Ondo State, to examine the phytoremediation potential of Codiaeum variegatum and Basella alba on contaminated soils from four locations. Soils were collected from the Mechanic workshop, Dumpsite, Forest Topsoils, and Effluent site, and filled into the buckets. Initial soil analysis was conducted on all the soils to determine heavy metal concentration (Cu, Cd, Ni, Pb, and Zn). At 12 weeks after planting, soil and plant (root and shoot) samples were analyzed to determine the heavy metals accumulated. WHO permissible limit value for heavy metal concentration in soil and plant were used as a standard to evaluate plant phytoremediation potential. Results from the study confirm the phytoremediation potential of C. variegatum and its high tolerance for the accumulation of heavy metals. B. alba plant also shows its potential in removing heavy metals from the soil, but it was not as tolerant as C. variegatum as B. alba planted in soils from mechanic workshop and effluent site had stunted growth.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/72786",risUrl:"/chapter/ris/72786",signatures:"Adeyela Ibironke Okunlola, Dotun Nathaniel Arije and Katherine Olayinka Olajugbagbe",book:{id:"9843",title:"Soil Contamination",subtitle:null,fullTitle:"Soil Contamination",slug:null,publishedDate:null,bookSignature:"Dr. Marcelo L. Larramendy and Dr. Sonia Soloneski",coverURL:"https://cdn.intechopen.com/books/images_new/9843.jpg",licenceType:"CC BY 3.0",editedByType:null,editors:[{id:"14764",title:"Dr.",name:"Marcelo L.",middleName:null,surname:"Larramendy",slug:"marcelo-l.-larramendy",fullName:"Marcelo L. Larramendy"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:null,sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Objective",level:"1"},{id:"sec_3",title:"3. Materials and methods",level:"1"},{id:"sec_4",title:"4. Results and discussion",level:"1"},{id:"sec_4_2",title:"4.1 Effect of heavy metal on plant growth parameters",level:"2"},{id:"sec_5_2",title:"4.2 Initial and final metal concentrations in plant tissues and in soils",level:"2"},{id:"sec_7",title:"5. Conclusion",level:"1"}],chapterReferences:[{id:"B1",body:'[\nWoranan N, Orapan M, Prasad M. Chapter 9: Potential of ornamental plants for phytoremediation of heavy metals and income generation. In: Prasad MNV, editor. Bioremediation and Bioeconomy. UK: Elsevier; 2016. pp. 177-217. DOI: 10.1016/B978-0-12-802830-8.00009-5\n]'},{id:"B2",body:'[\nAlaboudi K, Ahmed B, Brodie G. Phytoremediation of Pb and Cd contaminated soils by using sunflower (Helianthus annuus) plant. Annals of Agricultural Science. 2018;63(1):123-127. DOI: 10.1016/j.aoas.2018.05.007. ISSN: 0570-1783\n]'},{id:"B3",body:'[\nNica DV, Bura M, Gergen I, Harmanescu M, Bordean D-M. Bioaccumulative and conchological assessment of heavy metal transfer in a soil-plant-snail food chain. Chemistry Central Journal. 2012;6(1):55\n]'},{id:"B4",body:'[\nOrisakwe OE, Nduka JK, Amadi CN, Dike DO, Bede O. Heavy metals health risk assessment for population via consumption of food crops and fruits in Owerri, South Eastern, Nigeria. Chemistry Central Journal. 2012;6(1):77\n]'},{id:"B5",body:'[\nLiu H, Zhao H, Wu L, Liu A, Zhao F, Xu W. Heavy metal ATPase 3 (HMA3) confers cadmium hypertolerance on the cadmium/zinc hyperaccumulator Sedum plumbizincicola. The New Phytologist. 2017;215(2):687-698\n]'},{id:"B6",body:'[\nShuang C, Tingan Z, Shanlin Z, Ping L, Qixing Z, Qianru Z, et al. Evaluation of three ornamental plants for phytoremediation of Pb-contaminated soil. International Journal of Phytoremediation. 2013;15(4):299-306. DOI: 10.1080/15226514.2012.694502\n]'},{id:"B7",body:'[\nMiao Q, Yan J. Comparison of three ornamental plants for phytoextraction potential of chromium removal from tannery sludge. Journal of Material Cycles and Waste Management. 2013;15(1):98-105\n]'},{id:"B8",body:'[\nWang X, Zhou Q. Ecotoxicological effects of cadmium on three ornamental plants. Chemosphere. 2005;60(1):16-21\n]'},{id:"B9",body:'[\nShaltout A, Ibrahim M. Detection limit enhancement of Cd, Ni, Pb and Zn determined by flame atomic absorption spectroscopy. Canadian Journal of Analytical Sciences and Spectroscopy. 2007;52:5\n]'},{id:"B10",body:'[\nWorld Health Organization. Permissible Limits of Heavy Metals in Soil and Plants. Geneva, Switzerland: WHO; 1996\n]'},{id:"B11",body:'[\nGadd GM. Geomycology: Biogeochemical transformations of rocks, minerals, metals and radionuclides by fungi, bioweathering and bioremediation. Mycological Research. 2007;2007(111):3-49\n]'},{id:"B12",body:'[\nZhou W, Qiu B. Effects of cadmium hyperaccumulation on physiological characteristics of Sedum alfredii Hance (Crassulaceae). Plant Science. 2005;169:737-745\n]'},{id:"B13",body:'[\nGajewska E, Sklodowska M. Relations between tocopherol, chlorophyll and lipid peroxides contents in shots of Ni-treated wheat. Plant Physiology. 2007;164:364-366\n]'},{id:"B14",body:'[\nPandey N, Pathak GC. Nickel alters antioxidative defence and water status in greengram. Indian Journal of Plant Physiology. 2006;11:113-118\n]'},{id:"B15",body:'[\nRyser P, Sauder WR. Effects of heavy-metal-contaminated soil on growth, phenology and biomass turnover of Hieracium piloselloides. Environmental Pollutution. 2006;140:52-61\n]'}],footnotes:[],contributors:[{corresp:null,contributorFullName:"Adeyela Ibironke Okunlola",address:null,affiliation:'- Department of Crop, Soil, and Pest Management, The Federal University of Technology, Akure, Ondo State, Nigeria
'},{corresp:"yes",contributorFullName:"Dotun Nathaniel Arije",address:"dotunarije@gmail.com",affiliation:'- Department of Crop, Soil, and Pest Management, The Federal University of Technology, Akure, Ondo State, Nigeria
'},{corresp:null,contributorFullName:"Katherine Olayinka Olajugbagbe",address:null,affiliation:'- Department of Crop, Soil, and Pest Management, The Federal University of Technology, Akure, Ondo State, Nigeria
'}],corrections:null},book:{id:"9843",title:"Soil Contamination",subtitle:null,fullTitle:"Soil Contamination",slug:null,publishedDate:null,bookSignature:"Dr. Marcelo L. Larramendy and Dr. Sonia Soloneski",coverURL:"https://cdn.intechopen.com/books/images_new/9843.jpg",licenceType:"CC BY 3.0",editedByType:null,editors:[{id:"14764",title:"Dr.",name:"Marcelo L.",middleName:null,surname:"Larramendy",slug:"marcelo-l.-larramendy",fullName:"Marcelo L. Larramendy"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},profile:{item:{id:"294610",title:"MSc.",name:"Alessandro",middleName:null,surname:"Procaccini",email:"alessandro.procaccini@icsmaugeri.it",fullName:"Alessandro Procaccini",slug:"alessandro-procaccini",position:null,biography:null,institutionString:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",totalCites:0,totalChapterViews:"0",outsideEditionCount:0,totalAuthoredChapters:"1",totalEditedBooks:"0",personalWebsiteURL:null,twitterURL:null,linkedinURL:null,institution:null},booksEdited:[],chaptersAuthored:[{title:"Connected Insurance Reshaping the Health Insurance Industry",slug:"connected-insurance-reshaping-the-health-insurance-industry",abstract:"The role of today’s insurer is changing toward a more preventive and digital or connected approach. In this context, connected health insurance has the potential to contribute toward the health and the general well-being of the population. New technologies like e-health and wearables employed by the insurance industry might even help deal with major issues related to the rising number of people, of chronic disease patients, and of elders while keeping them healthier and at the same time protected by insurance. The aim of this chapter is to briefly illustrate the concept of “connected insurance” with specific focus on “connected health” and “wearables” and to present two case studies: Discovery’s Vitality program which aims to create healthier lifestyles for its customers through the use of wearables and rewards and ICS Maugeri’s MOSAIC project based on AI and predictive models aimed at helping with the management of treatment and quality of life in type 2 diabetes patients.",signatures:"Andrea Silvello and Alessandro Procaccini",authors:[{id:"288367",title:"Mr.",name:"Andrea",surname:"Silvello",fullName:"Andrea Silvello",slug:"andrea-silvello",email:"as@digitaltech-international.com"},{id:"294610",title:"MSc.",name:"Alessandro",surname:"Procaccini",fullName:"Alessandro Procaccini",slug:"alessandro-procaccini",email:"alessandro.procaccini@icsmaugeri.it"}],book:{title:"Smart Healthcare",slug:"smart-healthcare",productType:{id:"1",title:"Edited Volume"}}}],collaborators:[{id:"79143",title:"Prof.",name:"Andres",surname:"Navarro Cadavid",slug:"andres-navarro-cadavid",fullName:"Andres Navarro Cadavid",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Icesi University",institutionURL:null,country:{name:"Colombia"}}},{id:"272198",title:"Mr.",name:"Yor",surname:"Castano",slug:"yor-castano",fullName:"Yor Castano",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"285963",title:"Dr.",name:"Jorge",surname:"Orozco",slug:"jorge-orozco",fullName:"Jorge Orozco",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"285964",title:"Dr.",name:"Beatriz",surname:"Munoz",slug:"beatriz-munoz",fullName:"Beatriz Munoz",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"288367",title:"Mr.",name:"Andrea",surname:"Silvello",slug:"andrea-silvello",fullName:"Andrea Silvello",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"289049",title:"M.Sc.",name:"Delvin",surname:"Khan",slug:"delvin-khan",fullName:"Delvin Khan",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"289370",title:"Dr.",name:"Tulio",surname:"Maximo",slug:"tulio-maximo",fullName:"Tulio Maximo",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"294984",title:"Mr.",name:"Jaime",surname:"Valderrama",slug:"jaime-valderrama",fullName:"Jaime Valderrama",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"294985",title:"Ms.",name:"Linda",surname:"Montilla",slug:"linda-montilla",fullName:"Linda Montilla",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"294986",title:"Mr.",name:"Domiciano",surname:"Rincon",slug:"domiciano-rincon",fullName:"Domiciano Rincon",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null}]},generic:{page:{slug:"WIS-cost",title:"What Does It Cost?",intro:"Open Access publishing helps remove barriers and allows everyone to access valuable information, but article and book processing charges also exclude talented authors and editors who can’t afford to pay. The goal of our Women in Science program is to charge zero APCs, so none of our authors or editors have to pay for publication.
",metaTitle:"What Does It Cost?",metaDescription:"Open Access publishing helps remove barriers and allows everyone to access valuable information, but article and book processing charges also exclude talented authors and editors who can’t afford to pay. The goal of our Women in Science program is to charge zero APCs, so none of our authors or editors have to pay for publication.",metaKeywords:null,canonicalURL:null,contentRaw:'[{"type":"htmlEditorComponent","content":"We are currently in the process of collecting sponsorship. If you have any ideas or would like to help sponsor this ambitious program, we’d love to hear from you. Contact us at info@intechopen.com.
\\n\\nAll of our IntechOpen sponsors are in good company! The research in past IntechOpen books and chapters have been funded by:
\\n\\n\\n\\t- European Commission
\\n\\t- Bill and Melinda Gates Foundation
\\n\\t- Wellcome Trust
\\n\\t- National Institute of Health (NIH)
\\n\\t- National Science Foundation (NSF)
\\n\\t- National Institute of Standards and Technology (NIST)
\\n\\t- Research Councils United Kingdom (RCUK)
\\n\\t- Foundation for Science and Technology (FCT)
\\n\\t- Chinese Academy of Sciences
\\n\\t- Natural Science Foundation of China (NSFC)
\\n\\t- German Research Foundation (DFG)
\\n\\t- Max Planck Institute
\\n\\t- Austrian Science Fund (FWF)
\\n\\t- Australian Research Council (ARC)
\\n
\\n"}]'},components:[{type:"htmlEditorComponent",content:'We are currently in the process of collecting sponsorship. If you have any ideas or would like to help sponsor this ambitious program, we’d love to hear from you. Contact us at info@intechopen.com.
\n\nAll of our IntechOpen sponsors are in good company! The research in past IntechOpen books and chapters have been funded by:
\n\n\n\t- European Commission
\n\t- Bill and Melinda Gates Foundation
\n\t- Wellcome Trust
\n\t- National Institute of Health (NIH)
\n\t- National Science Foundation (NSF)
\n\t- National Institute of Standards and Technology (NIST)
\n\t- Research Councils United Kingdom (RCUK)
\n\t- Foundation for Science and Technology (FCT)
\n\t- Chinese Academy of Sciences
\n\t- Natural Science Foundation of China (NSFC)
\n\t- German Research Foundation (DFG)
\n\t- Max Planck Institute
\n\t- Austrian Science Fund (FWF)
\n\t- Australian Research Council (ARC)
\n
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/55578/images/4574_n.png",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:5766},{group:"region",caption:"Middle and South America",value:2,count:5227},{group:"region",caption:"Africa",value:3,count:1717},{group:"region",caption:"Asia",value:4,count:10367},{group:"region",caption:"Australia and Oceania",value:5,count:897},{group:"region",caption:"Europe",value:6,count:15790}],offset:12,limit:12,total:118189},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{hasNoEditors:"1",sort:"dateEndThirdStepPublish"},books:[{type:"book",id:"10231",title:"Proton Therapy",subtitle:null,isOpenForSubmission:!0,hash:"f4a9009287953c8d1d89f0fa9b7597b0",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10231.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10652",title:"Visual Object Tracking",subtitle:null,isOpenForSubmission:!0,hash:"96f3ee634a7ba49fa195e50475412af4",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10652.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10653",title:"Optimization Algorithms",subtitle:null,isOpenForSubmission:!0,hash:"753812dbb9a6f6b57645431063114f6c",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10653.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10655",title:"Motion Planning",subtitle:null,isOpenForSubmission:!0,hash:"809b5e290cf2dade9e7e0a5ae0ef3df0",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10655.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10657",title:"Service Robots",subtitle:null,isOpenForSubmission:!0,hash:"5f81b9eea6eb3f9af984031b7af35588",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10657.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10662",title:"Pedagogy",subtitle:null,isOpenForSubmission:!0,hash:"c858e1c6fb878d3b895acbacec624576",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10662.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10673",title:"The Psychology of Trust",subtitle:null,isOpenForSubmission:!0,hash:"1f6cac41fd145f718ac0866264499cc8",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10673.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10675",title:"Hydrostatics",subtitle:null,isOpenForSubmission:!0,hash:"c86c2fa9f835d4ad5e7efd8b01921866",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10675.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10677",title:"Topology",subtitle:null,isOpenForSubmission:!0,hash:"85eac84b173d785f989522397616124e",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10677.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10678",title:"Biostatistics",subtitle:null,isOpenForSubmission:!0,hash:"f63db439474a574454a66894db8b394c",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10678.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10679",title:"Mass Production",subtitle:null,isOpenForSubmission:!0,hash:"2dae91102099b1a07be1a36a68852829",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10679.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10684",title:"Biorefineries",subtitle:null,isOpenForSubmission:!0,hash:"23962c6b77348bcbf247c673d34562f6",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10684.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:6},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:6},{group:"topic",caption:"Business, Management and Economics",value:7,count:5},{group:"topic",caption:"Chemistry",value:8,count:1},{group:"topic",caption:"Computer and Information Science",value:9,count:5},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:3},{group:"topic",caption:"Engineering",value:11,count:6},{group:"topic",caption:"Environmental Sciences",value:12,count:4},{group:"topic",caption:"Immunology and Microbiology",value:13,count:2},{group:"topic",caption:"Mathematics",value:15,count:3},{group:"topic",caption:"Medicine",value:16,count:27},{group:"topic",caption:"Neuroscience",value:18,count:1},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:3},{group:"topic",caption:"Physics",value:20,count:2},{group:"topic",caption:"Psychology",value:21,count:3},{group:"topic",caption:"Robotics",value:22,count:4},{group:"topic",caption:"Social Sciences",value:23,count:3},{group:"topic",caption:"Technology",value:24,count:1}],offset:12,limit:12,total:86},popularBooks:{featuredBooks:[{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9027",title:"Human Blood Group Systems and Haemoglobinopathies",subtitle:null,isOpenForSubmission:!1,hash:"d00d8e40b11cfb2547d1122866531c7e",slug:"human-blood-group-systems-and-haemoglobinopathies",bookSignature:"Osaro Erhabor and Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/9027.jpg",editors:[{id:"35140",title:null,name:"Osaro",middleName:null,surname:"Erhabor",slug:"osaro-erhabor",fullName:"Osaro Erhabor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7841",title:"New Insights Into Metabolic Syndrome",subtitle:null,isOpenForSubmission:!1,hash:"ef5accfac9772b9e2c9eff884f085510",slug:"new-insights-into-metabolic-syndrome",bookSignature:"Akikazu Takada",coverURL:"https://cdn.intechopen.com/books/images_new/7841.jpg",editors:[{id:"248459",title:"Dr.",name:"Akikazu",middleName:null,surname:"Takada",slug:"akikazu-takada",fullName:"Akikazu Takada"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8558",title:"Aerodynamics",subtitle:null,isOpenForSubmission:!1,hash:"db7263fc198dfb539073ba0260a7f1aa",slug:"aerodynamics",bookSignature:"Mofid Gorji-Bandpy and Aly-Mousaad Aly",coverURL:"https://cdn.intechopen.com/books/images_new/8558.jpg",editors:[{id:"35542",title:"Prof.",name:"Mofid",middleName:null,surname:"Gorji-Bandpy",slug:"mofid-gorji-bandpy",fullName:"Mofid Gorji-Bandpy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9668",title:"Chemistry and Biochemistry of Winemaking, Wine Stabilization and Aging",subtitle:null,isOpenForSubmission:!1,hash:"c5484276a314628acf21ec1bdc3a86b9",slug:"chemistry-and-biochemistry-of-winemaking-wine-stabilization-and-aging",bookSignature:"Fernanda Cosme, Fernando M. Nunes and Luís Filipe-Ribeiro",coverURL:"https://cdn.intechopen.com/books/images_new/9668.jpg",editors:[{id:"186819",title:"Prof.",name:"Fernanda",middleName:null,surname:"Cosme",slug:"fernanda-cosme",fullName:"Fernanda Cosme"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7847",title:"Medical Toxicology",subtitle:null,isOpenForSubmission:!1,hash:"db9b65bea093de17a0855a1b27046247",slug:"medical-toxicology",bookSignature:"Pınar Erkekoglu and Tomohisa Ogawa",coverURL:"https://cdn.intechopen.com/books/images_new/7847.jpg",editors:[{id:"109978",title:"Prof.",name:"Pınar",middleName:null,surname:"Erkekoglu",slug:"pinar-erkekoglu",fullName:"Pınar Erkekoglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8620",title:"Mining Techniques",subtitle:"Past, Present and Future",isOpenForSubmission:!1,hash:"b65658f81d14e9e57e49377869d3a575",slug:"mining-techniques-past-present-and-future",bookSignature:"Abhay Soni",coverURL:"https://cdn.intechopen.com/books/images_new/8620.jpg",editors:[{id:"271093",title:"Dr.",name:"Abhay",middleName:null,surname:"Soni",slug:"abhay-soni",fullName:"Abhay Soni"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9660",title:"Inland Waters",subtitle:"Dynamics and Ecology",isOpenForSubmission:!1,hash:"975c26819ceb11a926793bc2adc62bd6",slug:"inland-waters-dynamics-and-ecology",bookSignature:"Adam Devlin, Jiayi Pan and Mohammad Manjur Shah",coverURL:"https://cdn.intechopen.com/books/images_new/9660.jpg",editors:[{id:"280757",title:"Dr.",name:"Adam",middleName:"Thomas",surname:"Devlin",slug:"adam-devlin",fullName:"Adam Devlin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9122",title:"Cosmetic Surgery",subtitle:null,isOpenForSubmission:!1,hash:"207026ca4a4125e17038e770d00ee152",slug:"cosmetic-surgery",bookSignature:"Yueh-Bih Tang",coverURL:"https://cdn.intechopen.com/books/images_new/9122.jpg",editors:[{id:"202122",title:"Prof.",name:"Yueh-Bih",middleName:null,surname:"Tang",slug:"yueh-bih-tang",fullName:"Yueh-Bih Tang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9043",title:"Parenting",subtitle:"Studies by an Ecocultural and Transactional Perspective",isOpenForSubmission:!1,hash:"6d21066c7438e459e4c6fb13217a5c8c",slug:"parenting-studies-by-an-ecocultural-and-transactional-perspective",bookSignature:"Loredana Benedetto and Massimo Ingrassia",coverURL:"https://cdn.intechopen.com/books/images_new/9043.jpg",editors:[{id:"193200",title:"Prof.",name:"Loredana",middleName:null,surname:"Benedetto",slug:"loredana-benedetto",fullName:"Loredana Benedetto"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9731",title:"Oxidoreductase",subtitle:null,isOpenForSubmission:!1,hash:"852e6f862c85fc3adecdbaf822e64e6e",slug:"oxidoreductase",bookSignature:"Mahmoud Ahmed Mansour",coverURL:"https://cdn.intechopen.com/books/images_new/9731.jpg",editors:[{id:"224662",title:"Prof.",name:"Mahmoud Ahmed",middleName:null,surname:"Mansour",slug:"mahmoud-ahmed-mansour",fullName:"Mahmoud Ahmed Mansour"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:5229},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9027",title:"Human Blood Group Systems and Haemoglobinopathies",subtitle:null,isOpenForSubmission:!1,hash:"d00d8e40b11cfb2547d1122866531c7e",slug:"human-blood-group-systems-and-haemoglobinopathies",bookSignature:"Osaro Erhabor and Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/9027.jpg",editors:[{id:"35140",title:null,name:"Osaro",middleName:null,surname:"Erhabor",slug:"osaro-erhabor",fullName:"Osaro Erhabor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7841",title:"New Insights Into Metabolic Syndrome",subtitle:null,isOpenForSubmission:!1,hash:"ef5accfac9772b9e2c9eff884f085510",slug:"new-insights-into-metabolic-syndrome",bookSignature:"Akikazu Takada",coverURL:"https://cdn.intechopen.com/books/images_new/7841.jpg",editors:[{id:"248459",title:"Dr.",name:"Akikazu",middleName:null,surname:"Takada",slug:"akikazu-takada",fullName:"Akikazu Takada"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8558",title:"Aerodynamics",subtitle:null,isOpenForSubmission:!1,hash:"db7263fc198dfb539073ba0260a7f1aa",slug:"aerodynamics",bookSignature:"Mofid Gorji-Bandpy and Aly-Mousaad Aly",coverURL:"https://cdn.intechopen.com/books/images_new/8558.jpg",editors:[{id:"35542",title:"Prof.",name:"Mofid",middleName:null,surname:"Gorji-Bandpy",slug:"mofid-gorji-bandpy",fullName:"Mofid Gorji-Bandpy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9668",title:"Chemistry and Biochemistry of Winemaking, Wine Stabilization and Aging",subtitle:null,isOpenForSubmission:!1,hash:"c5484276a314628acf21ec1bdc3a86b9",slug:"chemistry-and-biochemistry-of-winemaking-wine-stabilization-and-aging",bookSignature:"Fernanda Cosme, Fernando M. Nunes and Luís Filipe-Ribeiro",coverURL:"https://cdn.intechopen.com/books/images_new/9668.jpg",editors:[{id:"186819",title:"Prof.",name:"Fernanda",middleName:null,surname:"Cosme",slug:"fernanda-cosme",fullName:"Fernanda Cosme"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7847",title:"Medical Toxicology",subtitle:null,isOpenForSubmission:!1,hash:"db9b65bea093de17a0855a1b27046247",slug:"medical-toxicology",bookSignature:"Pınar Erkekoglu and Tomohisa Ogawa",coverURL:"https://cdn.intechopen.com/books/images_new/7847.jpg",editors:[{id:"109978",title:"Prof.",name:"Pınar",middleName:null,surname:"Erkekoglu",slug:"pinar-erkekoglu",fullName:"Pınar Erkekoglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8620",title:"Mining Techniques",subtitle:"Past, Present and Future",isOpenForSubmission:!1,hash:"b65658f81d14e9e57e49377869d3a575",slug:"mining-techniques-past-present-and-future",bookSignature:"Abhay Soni",coverURL:"https://cdn.intechopen.com/books/images_new/8620.jpg",editors:[{id:"271093",title:"Dr.",name:"Abhay",middleName:null,surname:"Soni",slug:"abhay-soni",fullName:"Abhay Soni"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9660",title:"Inland Waters",subtitle:"Dynamics and Ecology",isOpenForSubmission:!1,hash:"975c26819ceb11a926793bc2adc62bd6",slug:"inland-waters-dynamics-and-ecology",bookSignature:"Adam Devlin, Jiayi Pan and Mohammad Manjur Shah",coverURL:"https://cdn.intechopen.com/books/images_new/9660.jpg",editors:[{id:"280757",title:"Dr.",name:"Adam",middleName:"Thomas",surname:"Devlin",slug:"adam-devlin",fullName:"Adam Devlin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9122",title:"Cosmetic Surgery",subtitle:null,isOpenForSubmission:!1,hash:"207026ca4a4125e17038e770d00ee152",slug:"cosmetic-surgery",bookSignature:"Yueh-Bih Tang",coverURL:"https://cdn.intechopen.com/books/images_new/9122.jpg",editors:[{id:"202122",title:"Prof.",name:"Yueh-Bih",middleName:null,surname:"Tang",slug:"yueh-bih-tang",fullName:"Yueh-Bih Tang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editedByType:"Edited by",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editedByType:"Edited by",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9313",title:"Clay Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"6fa7e70396ff10620e032bb6cfa6fb72",slug:"clay-science-and-technology",bookSignature:"Gustavo Morari Do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/9313.jpg",editedByType:"Edited by",editors:[{id:"7153",title:"Prof.",name:"Gustavo",middleName:null,surname:"Morari Do Nascimento",slug:"gustavo-morari-do-nascimento",fullName:"Gustavo Morari Do Nascimento"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9888",title:"Nuclear Power Plants",subtitle:"The Processes from the Cradle to the Grave",isOpenForSubmission:!1,hash:"c2c8773e586f62155ab8221ebb72a849",slug:"nuclear-power-plants-the-processes-from-the-cradle-to-the-grave",bookSignature:"Nasser Awwad",coverURL:"https://cdn.intechopen.com/books/images_new/9888.jpg",editedByType:"Edited by",editors:[{id:"145209",title:"Prof.",name:"Nasser",middleName:"S",surname:"Awwad",slug:"nasser-awwad",fullName:"Nasser Awwad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8098",title:"Resources of Water",subtitle:null,isOpenForSubmission:!1,hash:"d251652996624d932ef7b8ed62cf7cfc",slug:"resources-of-water",bookSignature:"Prathna Thanjavur Chandrasekaran, Muhammad Salik Javaid, Aftab Sadiq",coverURL:"https://cdn.intechopen.com/books/images_new/8098.jpg",editedByType:"Edited by",editors:[{id:"167917",title:"Dr.",name:"Prathna",middleName:null,surname:"Thanjavur Chandrasekaran",slug:"prathna-thanjavur-chandrasekaran",fullName:"Prathna Thanjavur Chandrasekaran"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editedByType:"Edited by",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10432",title:"Casting Processes and Modelling of Metallic Materials",subtitle:null,isOpenForSubmission:!1,hash:"2c5c9df938666bf5d1797727db203a6d",slug:"casting-processes-and-modelling-of-metallic-materials",bookSignature:"Zakaria Abdallah and Nada Aldoumani",coverURL:"https://cdn.intechopen.com/books/images_new/10432.jpg",editedByType:"Edited by",editors:[{id:"201670",title:"Dr.",name:"Zak",middleName:null,surname:"Abdallah",slug:"zak-abdallah",fullName:"Zak Abdallah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9671",title:"Macrophages",subtitle:null,isOpenForSubmission:!1,hash:"03b00fdc5f24b71d1ecdfd75076bfde6",slug:"macrophages",bookSignature:"Hridayesh Prakash",coverURL:"https://cdn.intechopen.com/books/images_new/9671.jpg",editedByType:"Edited by",editors:[{id:"287184",title:"Dr.",name:"Hridayesh",middleName:null,surname:"Prakash",slug:"hridayesh-prakash",fullName:"Hridayesh Prakash"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8415",title:"Extremophilic Microbes and Metabolites",subtitle:"Diversity, Bioprospecting and Biotechnological Applications",isOpenForSubmission:!1,hash:"93e0321bc93b89ff73730157738f8f97",slug:"extremophilic-microbes-and-metabolites-diversity-bioprospecting-and-biotechnological-applications",bookSignature:"Afef Najjari, Ameur Cherif, Haïtham Sghaier and Hadda Imene Ouzari",coverURL:"https://cdn.intechopen.com/books/images_new/8415.jpg",editedByType:"Edited by",editors:[{id:"196823",title:"Dr.",name:"Afef",middleName:null,surname:"Najjari",slug:"afef-najjari",fullName:"Afef Najjari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9731",title:"Oxidoreductase",subtitle:null,isOpenForSubmission:!1,hash:"852e6f862c85fc3adecdbaf822e64e6e",slug:"oxidoreductase",bookSignature:"Mahmoud Ahmed Mansour",coverURL:"https://cdn.intechopen.com/books/images_new/9731.jpg",editedByType:"Edited by",editors:[{id:"224662",title:"Prof.",name:"Mahmoud Ahmed",middleName:null,surname:"Mansour",slug:"mahmoud-ahmed-mansour",fullName:"Mahmoud Ahmed Mansour"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"124",title:"Vehicle Engineering",slug:"vehicle-engineering",parent:{title:"Engineering",slug:"engineering"},numberOfBooks:24,numberOfAuthorsAndEditors:654,numberOfWosCitations:877,numberOfCrossrefCitations:558,numberOfDimensionsCitations:1150,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicSlug:"vehicle-engineering",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"8840",title:"Intelligent and Efficient Transport Systems",subtitle:"Design, Modelling, Control and Simulation",isOpenForSubmission:!1,hash:"74ab35ec9e85ba37428df986d3a280ff",slug:"intelligent-and-efficient-transport-systems-design-modelling-control-and-simulation",bookSignature:"Truong Quang Dinh",coverURL:"https://cdn.intechopen.com/books/images_new/8840.jpg",editedByType:"Edited by",editors:[{id:"181747",title:"Dr.",name:"Truong Quang",middleName:null,surname:"Dinh",slug:"truong-quang-dinh",fullName:"Truong Quang Dinh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7377",title:"Diesel and Gasoline Engines",subtitle:null,isOpenForSubmission:!1,hash:"dab9fe312a28dd603ac4b21628070d59",slug:"diesel-and-gasoline-engines",bookSignature:"Richard Viskup",coverURL:"https://cdn.intechopen.com/books/images_new/7377.jpg",editedByType:"Edited by",editors:[{id:"103742",title:"Dr.",name:"Richard",middleName:null,surname:"Viskup",slug:"richard-viskup",fullName:"Richard Viskup"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7408",title:"Transportation Systems Analysis and Assessment",subtitle:null,isOpenForSubmission:!1,hash:"1a950b01c0e05eda01c6d2364c7af3aa",slug:"transportation-systems-analysis-and-assessment",bookSignature:"Stefano De Luca, Roberta Di Pace and Boban Djordjevic",coverURL:"https://cdn.intechopen.com/books/images_new/7408.jpg",editedByType:"Edited by",editors:[{id:"271061",title:"Prof.",name:"Stefano",middleName:null,surname:"de Luca",slug:"stefano-de-luca",fullName:"Stefano de Luca"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7198",title:"Propulsion Systems",subtitle:null,isOpenForSubmission:!1,hash:"fd56f1620b0b201a3de0cd3f7e04d15c",slug:"propulsion-systems",bookSignature:"Alessandro Serpi and Mario Porru",coverURL:"https://cdn.intechopen.com/books/images_new/7198.jpg",editedByType:"Edited by",editors:[{id:"217145",title:"Dr.",name:"Alessandro",middleName:null,surname:"Serpi",slug:"alessandro-serpi",fullName:"Alessandro Serpi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6767",title:"New Trends in Electrical Vehicle Powertrains",subtitle:null,isOpenForSubmission:!1,hash:"92949d7c2133b98bbddb02a9037c1dc7",slug:"new-trends-in-electrical-vehicle-powertrains",bookSignature:"Luis Romeral Martínez and Miguel Delgado Prieto",coverURL:"https://cdn.intechopen.com/books/images_new/6767.jpg",editedByType:"Edited by",editors:[{id:"86501",title:"Dr.",name:"Luis",middleName:null,surname:"Romeral Martinez",slug:"luis-romeral-martinez",fullName:"Luis Romeral Martinez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6065",title:"Modern Railway Engineering",subtitle:null,isOpenForSubmission:!1,hash:"77a5fae5e9451d4e52e9f7cd8f39bdcb",slug:"modern-railway-engineering",bookSignature:"Ali Hessami",coverURL:"https://cdn.intechopen.com/books/images_new/6065.jpg",editedByType:"Edited by",editors:[{id:"108303",title:"Prof.",name:"Ali G.",middleName:null,surname:"Hessami",slug:"ali-g.-hessami",fullName:"Ali G. Hessami"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5910",title:"Hybrid Electric Vehicles",subtitle:null,isOpenForSubmission:!1,hash:"92354b49c166c70707d576852b82a9f1",slug:"hybrid-electric-vehicles",bookSignature:"Teresa Donateo",coverURL:"https://cdn.intechopen.com/books/images_new/5910.jpg",editedByType:"Edited by",editors:[{id:"139190",title:"Prof.",name:"Teresa",middleName:null,surname:"Donateo",slug:"teresa-donateo",fullName:"Teresa Donateo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5423",title:"Urban Transport Systems",subtitle:null,isOpenForSubmission:!1,hash:"222b5d90a7014dbff7e33f3dcde6bc1d",slug:"urban-transport-systems",bookSignature:"Hamid Yaghoubi",coverURL:"https://cdn.intechopen.com/books/images_new/5423.jpg",editedByType:"Edited by",editors:[{id:"103965",title:"Dr.",name:"Hamid",middleName:null,surname:"Yaghoubi",slug:"hamid-yaghoubi",fullName:"Hamid Yaghoubi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5299",title:"Modeling and Simulation for Electric Vehicle Applications",subtitle:null,isOpenForSubmission:!1,hash:"42a1e112f18751417613cf1524500467",slug:"modeling-and-simulation-for-electric-vehicle-applications",bookSignature:"Mohamed Amine Fakhfakh",coverURL:"https://cdn.intechopen.com/books/images_new/5299.jpg",editedByType:"Edited by",editors:[{id:"35742",title:"Dr.",name:"Mohamed Amine",middleName:null,surname:"Fakhfakh",slug:"mohamed-amine-fakhfakh",fullName:"Mohamed Amine Fakhfakh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4789",title:"Railway Research",subtitle:"Selected Topics on Development, Safety and Technology",isOpenForSubmission:!1,hash:"2dc03e93f4357a3a62292097597576ad",slug:"railway-research-selected-topics-on-development-safety-and-technology",bookSignature:"Krzysztof Zboinski",coverURL:"https://cdn.intechopen.com/books/images_new/4789.jpg",editedByType:"Edited by",editors:[{id:"174599",title:"Prof.",name:"Krzysztof",middleName:null,surname:"Zboinski",slug:"krzysztof-zboinski",fullName:"Krzysztof Zboinski"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2432",title:"Diesel Engine",subtitle:"Combustion, Emissions and Condition Monitoring",isOpenForSubmission:!1,hash:"cb6fadd8a5559c52b00c5ee471200cea",slug:"diesel-engine-combustion-emissions-and-condition-monitoring",bookSignature:"Saiful Bari",coverURL:"https://cdn.intechopen.com/books/images_new/2432.jpg",editedByType:"Edited by",editors:[{id:"128876",title:"Dr.",name:"Saiful",middleName:null,surname:"Bari",slug:"saiful-bari",fullName:"Saiful Bari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3512",title:"Advances in Internal Combustion Engines and Fuel Technologies",subtitle:null,isOpenForSubmission:!1,hash:"dad7da72b338235c14a67b3f2fa400a9",slug:"advances-in-internal-combustion-engines-and-fuel-technologies",bookSignature:"Hoon Kiat Ng",coverURL:"https://cdn.intechopen.com/books/images_new/3512.jpg",editedByType:"Edited by",editors:[{id:"150667",title:"Dr.",name:"Hoon Kiat",middleName:null,surname:"Ng",slug:"hoon-kiat-ng",fullName:"Hoon Kiat Ng"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:24,mostCitedChapters:[{id:"13349",doi:"10.5772/14086",title:"High Mn TWIP Steels for Automotive Applications",slug:"high-mn-twip-steels-for-automotive-applications",totalDownloads:12232,totalCrossrefCites:47,totalDimensionsCites:118,book:{slug:"new-trends-and-developments-in-automotive-system-engineering",title:"New Trends and Developments in Automotive System Engineering",fullTitle:"New Trends and Developments in Automotive System Engineering"},signatures:"B. C. De Cooman, Kwang-geun Chin and Jinkyung Kim",authors:[{id:"16743",title:"Prof.",name:"Bruno Charles",middleName:null,surname:"De Cooman",slug:"bruno-charles-de-cooman",fullName:"Bruno Charles De Cooman"}]},{id:"13343",doi:"10.5772/13286",title:"Materials in Automotive Application, State of the Art and Prospects",slug:"materials-in-automotive-application-state-of-the-art-and-prospects",totalDownloads:64314,totalCrossrefCites:36,totalDimensionsCites:75,book:{slug:"new-trends-and-developments-in-automotive-industry",title:"New Trends and Developments in Automotive Industry",fullTitle:"New Trends and Developments in Automotive Industry"},signatures:"Elaheh Ghassemieh",authors:[{id:"13695",title:"Dr.",name:"Elaheh",middleName:null,surname:"Ghassemieh",slug:"elaheh-ghassemieh",fullName:"Elaheh Ghassemieh"}]},{id:"42787",doi:"10.5772/55492",title:"Smart Vehicles, Technologies and Main Applications in Vehicular Ad hoc Networks",slug:"smart-vehicles-technologies-and-main-applications-in-vehicular-ad-hoc-networks",totalDownloads:6012,totalCrossrefCites:12,totalDimensionsCites:46,book:{slug:"vehicular-technologies-deployment-and-applications",title:"Vehicular Technologies",fullTitle:"Vehicular Technologies - Deployment and Applications"},signatures:"Anna Maria Vegni, Mauro Biagi and Roberto Cusani",authors:[{id:"19747",title:"Dr.",name:"Anna Maria",middleName:null,surname:"Vegni",slug:"anna-maria-vegni",fullName:"Anna Maria Vegni"},{id:"19749",title:"Prof.",name:"Roberto",middleName:null,surname:"Cusani",slug:"roberto-cusani",fullName:"Roberto Cusani"},{id:"159351",title:"Dr.",name:"Mauro",middleName:null,surname:"Biagi",slug:"mauro-biagi",fullName:"Mauro Biagi"}]}],mostDownloadedChaptersLast30Days:[{id:"19583",title:"DC/DC Converters for Electric Vehicles",slug:"dc-dc-converters-for-electric-vehicles",totalDownloads:21759,totalCrossrefCites:11,totalDimensionsCites:32,book:{slug:"electric-vehicles-modelling-and-simulations",title:"Electric Vehicles",fullTitle:"Electric Vehicles - Modelling and Simulations"},signatures:"Monzer Al Sakka, Joeri Van Mierlo and Hamid Gualous",authors:[{id:"27098",title:"Dr.",name:"Monzer",middleName:null,surname:"Al Sakka",slug:"monzer-al-sakka",fullName:"Monzer Al Sakka"},{id:"40637",title:"Prof.",name:"Joeri",middleName:null,surname:"Van Mierlo",slug:"joeri-van-mierlo",fullName:"Joeri Van Mierlo"},{id:"40638",title:"Prof.",name:"Hamid",middleName:null,surname:"Gualous",slug:"hamid-gualous",fullName:"Hamid Gualous"}]},{id:"60938",title:"Electric Vehicles Integrated with Renewable Energy Sources for Sustainable Mobility",slug:"electric-vehicles-integrated-with-renewable-energy-sources-for-sustainable-mobility",totalDownloads:3002,totalCrossrefCites:3,totalDimensionsCites:9,book:{slug:"new-trends-in-electrical-vehicle-powertrains",title:"New Trends in Electrical Vehicle Powertrains",fullTitle:"New Trends in Electrical Vehicle Powertrains"},signatures:"Michela Longo, Federica Foiadelli and Wahiba Yaïci",authors:[{id:"238927",title:"Prof.",name:"Michela",middleName:null,surname:"Longo",slug:"michela-longo",fullName:"Michela Longo"},{id:"240528",title:"Dr.",name:"Wahiba",middleName:null,surname:"Yaïci",slug:"wahiba-yaici",fullName:"Wahiba Yaïci"},{id:"240529",title:"Prof.",name:"Federica",middleName:null,surname:"Foiadelli",slug:"federica-foiadelli",fullName:"Federica Foiadelli"}]},{id:"64509",title:"Options and Evaluations on Propulsion Systems of LNG Carriers",slug:"options-and-evaluations-on-propulsion-systems-of-lng-carriers",totalDownloads:3078,totalCrossrefCites:2,totalDimensionsCites:4,book:{slug:"propulsion-systems",title:"Propulsion Systems",fullTitle:"Propulsion Systems"},signatures:"Tu Huan, Fan Hongjun, Lei Wei and Zhou Guoqiang",authors:[{id:"265951",title:"Mr.",name:"Huan",middleName:null,surname:"Tu",slug:"huan-tu",fullName:"Huan Tu"}]},{id:"61412",title:"Model Based System Design for Electric Vehicle Conversion",slug:"model-based-system-design-for-electric-vehicle-conversion",totalDownloads:1921,totalCrossrefCites:0,totalDimensionsCites:1,book:{slug:"new-trends-in-electrical-vehicle-powertrains",title:"New Trends in Electrical Vehicle Powertrains",fullTitle:"New Trends in Electrical Vehicle Powertrains"},signatures:"Ananchai Ukaew",authors:[{id:"239213",title:"Dr.",name:"Ananchai",middleName:null,surname:"Ukaew",slug:"ananchai-ukaew",fullName:"Ananchai Ukaew"}]},{id:"52321",title:"Passenger Exposure to Magnetic Fields in Electric Vehicles",slug:"passenger-exposure-to-magnetic-fields-in-electric-vehicles",totalDownloads:2831,totalCrossrefCites:4,totalDimensionsCites:7,book:{slug:"modeling-and-simulation-for-electric-vehicle-applications",title:"Modeling and Simulation for Electric Vehicle Applications",fullTitle:"Modeling and Simulation for Electric Vehicle Applications"},signatures:"Pablo Moreno‐Torres, Marcos Lafoz, Marcos Blanco and Jaime R.\nArribas",authors:[{id:"182907",title:"Dr.",name:"Pablo",middleName:null,surname:"Moreno-Torres",slug:"pablo-moreno-torres",fullName:"Pablo Moreno-Torres"}]},{id:"69204",title:"Fuels of the Diesel-Gasoline Engines and Their Properties",slug:"fuels-of-the-diesel-gasoline-engines-and-their-properties",totalDownloads:649,totalCrossrefCites:2,totalDimensionsCites:4,book:{slug:"diesel-and-gasoline-engines",title:"Diesel and Gasoline Engines",fullTitle:"Diesel and Gasoline Engines"},signatures:"Selçuk Sarıkoç",authors:[{id:"308175",title:"Dr.",name:"Selçuk",middleName:null,surname:"Sarıkoç",slug:"selcuk-sarikoc",fullName:"Selçuk Sarıkoç"}]},{id:"18662",title:"Electric Vehicles in an Urban Context: Environmental Benefits and Techno-Economic Barriers",slug:"electric-vehicles-in-an-urban-context-environmental-benefits-and-techno-economic-barriers",totalDownloads:4136,totalCrossrefCites:4,totalDimensionsCites:8,book:{slug:"electric-vehicles-the-benefits-and-barriers",title:"Electric Vehicles",fullTitle:"Electric Vehicles - The Benefits and Barriers"},signatures:"Adolfo Perujo, Christian Thiel and Françoise Nemry",authors:[{id:"40430",title:"Dr.",name:"Adolfo",middleName:null,surname:"Perujo",slug:"adolfo-perujo",fullName:"Adolfo Perujo"},{id:"41647",title:"Mr.",name:"Christian",middleName:null,surname:"Thiel",slug:"christian-thiel",fullName:"Christian Thiel"},{id:"41648",title:"Ms.",name:"Françoise",middleName:null,surname:"Nemry",slug:"francoise-nemry",fullName:"Françoise Nemry"}]},{id:"41417",title:"Batteries and Supercapacitors for Electric Vehicles",slug:"batteries-and-supercapacitors-for-electric-vehicles",totalDownloads:5570,totalCrossrefCites:5,totalDimensionsCites:11,book:{slug:"new-generation-of-electric-vehicles",title:"New Generation of Electric Vehicles",fullTitle:"New Generation of Electric Vehicles"},signatures:"Monzer Al Sakka, Hamid Gualous, Noshin Omar and Joeri Van Mierlo",authors:[{id:"27098",title:"Dr.",name:"Monzer",middleName:null,surname:"Al Sakka",slug:"monzer-al-sakka",fullName:"Monzer Al Sakka"},{id:"40637",title:"Prof.",name:"Joeri",middleName:null,surname:"Van Mierlo",slug:"joeri-van-mierlo",fullName:"Joeri Van Mierlo"},{id:"40638",title:"Prof.",name:"Hamid",middleName:null,surname:"Gualous",slug:"hamid-gualous",fullName:"Hamid Gualous"},{id:"154579",title:"Dr.",name:"Noshin",middleName:null,surname:"Omar",slug:"noshin-omar",fullName:"Noshin Omar"}]},{id:"18666",title:"Fuel Cell Hybrid Electric Vehicles",slug:"fuel-cell-hybrid-electric-vehicles",totalDownloads:7160,totalCrossrefCites:3,totalDimensionsCites:7,book:{slug:"electric-vehicles-the-benefits-and-barriers",title:"Electric Vehicles",fullTitle:"Electric Vehicles - The Benefits and Barriers"},signatures:"Nicola Briguglio, Laura Andaloro, Marco Ferraro and Vincenzo Antonucci",authors:[{id:"32072",title:"Dr.",name:"Nicola",middleName:null,surname:"Briguglio",slug:"nicola-briguglio",fullName:"Nicola Briguglio"},{id:"40746",title:"Dr.",name:"Marco",middleName:null,surname:"Ferraro",slug:"marco-ferraro",fullName:"Marco Ferraro"},{id:"40747",title:"Dr.",name:"Laura",middleName:null,surname:"Andaloro",slug:"laura-andaloro",fullName:"Laura Andaloro"},{id:"40748",title:"Dr.",name:"Vincenzo",middleName:null,surname:"Antonucci",slug:"vincenzo-antonucci",fullName:"Vincenzo Antonucci"}]},{id:"18661",title:"A Survey on Electric and Hybrid Electric Vehicle Technology",slug:"a-survey-on-electric-and-hybrid-electric-vehicle-technology",totalDownloads:5572,totalCrossrefCites:7,totalDimensionsCites:12,book:{slug:"electric-vehicles-the-benefits-and-barriers",title:"Electric Vehicles",fullTitle:"Electric Vehicles - The Benefits and Barriers"},signatures:"Samuel E. de Lucena",authors:[{id:"30228",title:"Prof.",name:"Samuel",middleName:"E. De",surname:"Lucena",slug:"samuel-lucena",fullName:"Samuel Lucena"}]}],onlineFirstChaptersFilter:{topicSlug:"vehicle-engineering",limit:3,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[{type:"book",id:"10176",title:"Microgrids and Local Energy Systems",subtitle:null,isOpenForSubmission:!0,hash:"c32b4a5351a88f263074b0d0ca813a9c",slug:null,bookSignature:"Prof. Nick Jenkins",coverURL:"https://cdn.intechopen.com/books/images_new/10176.jpg",editedByType:null,editors:[{id:"55219",title:"Prof.",name:"Nick",middleName:null,surname:"Jenkins",slug:"nick-jenkins",fullName:"Nick Jenkins"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:8,limit:8,total:1},route:{name:"onlineFirst.detail",path:"/online-first/evaluation-of-ornamental-plants-for-phytoremediation-of-contaminated-soil",hash:"",query:{},params:{chapter:"evaluation-of-ornamental-plants-for-phytoremediation-of-contaminated-soil"},fullPath:"/online-first/evaluation-of-ornamental-plants-for-phytoremediation-of-contaminated-soil",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()